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ABSTRACT 
 
PEIYING ZUO: Modeling the Airway Surface Liquid Regulation in Human Lungs. 
(Under the direction of Timothy Elston and Richard Boucher) 
 
 
 
The research in this dissertation is aimed at understanding the pathogenesis of 
Cystic Fibrosis, which is a life-threatening disorder that causes severe lung damage and 
nutritional deficiencies. Patients with cystic fibrosis exhibit deficient mucociliary 
clearance due to enhanced thickness and adherence of the mucus in their airway. In the 
past a few decades, significant progress has been made in understanding the cause of the 
disease as well as ways to treat it. Besides conventional treatments for cystic fibrosis, the 
addition of adenine triphosphate (ATP) to the airway surface of the lung was recently 
found to be effective to restore mucociliary clearance. Even as scientists begin to 
understand the signaling pathways that regulate the airway surface liquid (ASL), there are 
still many parts of this complex system that remain unclear. The ultimate goal of this 
work is to put together several important “puzzle pieces”, and try to understand how 
proper regulation of the ASL is achieved. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 HISTORY AND MOTIVIATION    
The principal function of the human lung is to transport oxygen from the 
atmosphere into the bloodstream, and to excrete carbon dioxide from the bloodstream into 
the atmosphere. Respiration occurs in a series of steps. Air is brought into the body via 
the airways , from the nose to the pharynx, the larynx, the trachea, bronchi, bronchioles 
and the alveolar sacs forming the terminal branches of the respiratory tree (Figure 1). The 
exchange of gases is accomplished by the sacs of specialized cells that form millions of 
tiny, exceptionally thin-walled air sacs called alveoli. 
The airways also present natural defense mechanisms against infections. The 
ciliated epithelial surfaces of the airways are shielded by a mucus layer which traps 
inhaled particles and is continuously removed from the airways by ciliary beating 
activity. The mucus, secreted by superficial epithelium and goblet cells, is normally clear 
and think filtering air during inhalation. During times of infection, mucus can change 
color as a result of trapped bacteria, while in some other diseases such as cystic fibrosis, a 
consistency change can occur due to water loss and high salt concentrations.  
Lung disease is the number three killer in America, responsible for one in seven 
deaths. Along with other breathing problems, it is also the number one killer of babies 
younger than one year. Today, more than 35 million Americans are living with chronic
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lung diseases such as asthma, emphysema and chronic bronchitis. In this dissertation, our 
focus is the lung disease called cystic fibrosis.  
In medieval folklore, infants with salty skin, a symptom of cystic fibrosis, are 
 
Figure 1: The structure of the human respiratory 
system (from http:// www.lungusa.org) 
 
considered "bewitched" because they routinely die an early death. As sciences advanced, 
more about this disease has gradually been revealed. Cystic fibrosis (CF) is an inherited 
chronic disease that affects the lungs and digestive systems of about 30,000 children and 
adults in the United States (70,000 worldwide). It is most prevalent amongst European 
and Ashkenazi Jews. One in twenty-two people of European descent carries one gene for 
CF, making it the most common genetic disease among them. CF does not follow the 
same pattern in all patients but affects different people in different ways and to varying 
degrees. It affects the entire body, but symptoms begin mostly in the lungs. Some 
common symptoms include coughing, repeated lung infections, shortness of breath, poor 
growth, intestinal blockage, and infertility, all dominated by functional abnormalities in 
the glands that produce or secrete sweat and mucus. Sweat cools the body; mucus 
lubricates the respiratory, digestive, and reproductive systems and prevents tissues from 
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drying out, protecting them from infection. The lungs of CF patients produce excess 
thick, sticky mucus that clogs the airways, causing breathing problems and providing a 
breeding ground for bacteria to grow, which leads to frequent lung infections, damages to 
the lungs and contributes to early death. Thick fluid may also clog pancreatic ducts and 
prevent digestive fluids from reaching the small intestine, which causes digestive 
problems and slows growth. The conventional treatments for CF-related lung 
complications are chest percussion or other ways of clearing mucus. Antibiotics are often 
used to fight infection. There is no cure for CF and most patients die young – many in 
their 20s and 30s from lung failure. A Lung transplant is often necessary as CF 
progresses.  Besides the conventional treatments, scientists are also working on finding a 
gene-based therapies based on the identification of CF gene two decades ago. 
A 
 
B 
 
Figure 2: Gene location of CFTR. The approximate gene location of CFTR is based on 
Chromosome 7 map from NCBI Entrez Map Viewer (A). Figure2B: The ∆F508 deletion is the 
most common cause of cystic fibrosis. The isoleucine (Ile) at amino acid position 507 remains 
unchanged because both ATC and ATT code for isoleucine (From Genomics.energy.gov) 
 
The identification of cystic fibrosis disease is traced back to the 1930s when it was 
first referred to as “cystic fibromatosis with bronchiectasis”. Andersen et  al. developed 
the first comprehensive description of cystic fibrosis symptoms in 1938. About fifteen 
years later di Sant’ Agnese formally reported excessive amounts of salt in the CF 
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patients’ sweat. In 1985, Tsui and co-workers [1, 2, 3] discovered the gene responsible for 
CF and named its protein product “Cystic Fibrosis Transmembrane Conductance 
Regulator (CFTR)” which was mapped to the long arm of chromosome 7q (Fig2A). Both 
copies of the gene need to be defective for a person to develop the disease. CFTR is an 
essential protein found in the epithelial cells that line the body's internal passageways, 
including the lungs, pancreas, colon, and genitourinary tract. It is responsible for moving 
chloride ions (Cl
-
) through the cell membrane. In 70% to 80% of all CF cases, three of the 
base pairs in the gene are deleted and the amino acid that the triad codes for 
(phenylalanine) is not generated. The abnormal protein is called ∆F508 CFTR (Fig2B). 
The other 20% to 30% of CF cases result from one of hundreds of other possible 
mutations that can lead to abnormal CFTR function.  
The finding of the CF gene makes gene therapy a natural candidate for treatment 
of cystic. Gene therapy is the insertion of genes into an individual's cells and tissues to 
treat a disease. Cystic fibrosis ultimately could be cured if safe and effective methods are 
found to replace the defective CFTR gene with an intact gene in affected tissues. In the 
case of cystic fibrosis, gene therapy would involve inhaling a spray that delivers normal 
DNA to the lung. During such a treatment, shuttle vehicles called vectors deliver a 
functional copy of the defective gene-in this case, CFTR-either to cells throughout the 
airways. Once the new CFTR gene has entered the cell, the biochemical machinery must 
recognize it and use it as a template for the production of functional protein. However, 
despite an impressive amount of research in this area, there is little evidence to suggest 
that an effective gene-transfer approach for the treatment of CF lung disease is imminent. 
The inability to produce such a therapy reflects in part the learning curve with respect to 
vector technology and the failure to appreciate the capacity of the airway epithelial cells 
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to defend themselves against the penetration by moieties, including gene-therapy vectors, 
from the outside world. 
Meanwhile, the general recognition that CF lung disease reflects a failure of the 
innate defense of airways against bacterial infection leads to a search focusing on 
identifying the nature of the normal innate defense of the airways against bacterial 
infections and how mutations in the CF transmembrane conductance regulator (CFTR) 
gene perturb these mechanisms. It is generally believed that airway surface dehydration 
produces leads to mucus adhesion, inflammation and bacterial biofilm formation [4, 5, 
6].The characterization of well-differentiated cultures of airway epithelial cell culture  
revealed that the  airway surface liquid (ASL) is divided into a well-defined periciliary 
liquid (PCL) layer and a mucus layer. Recent studies have shown that liquid can be added 
to, or removed from, the mucus layer without altering the height of the PCL layer. 
Specifically, the studies showed that removing approximately 50% of the liquid from the 
ASL compartment led to selective reduction in the volume of the mucus layer, with 
preservation of the PCL layer, and at least partial preservation of mucus transport. 
Conversely, when the ASL volume was doubled, liquid entered the mucus layer, the PCL 
layer maintained its volume, and interestingly, the mucus transport rates increased. 
Further studies revealed that when 70% or more of the volume was removed from the 
ASL compartment, the mucus layer could no longer effectively “donate” liquid to the 
PCL layer, volume was lost from the PCL, and mucus transport ceased. The upper limit 
of volume addition to the mucus layer was not determined in these studies. One 
implication of these findings is that as liquid in vivo converges onto a single airway from 
two smaller airways, the excess liquid deposited on the single airway from two distal 
airways may be transiently “stored” in the mucus layer, with preservation of PCL layer 
height and mucus transport. Presumably the excess liquid (salt and water) will be 
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removed by transepithelial ion transport from the mucus layer as the ASL moves up the 
singe airway. In contrast, when water loss occurs at the surface of proximal airways due 
to exercise-induced evaporation, the volume is selectively lost from the mucus layer, with 
preservation of PCL and mucus transport.  
 
Figure 3: Regulation of the volume of periciliary liquid (PCL) layer by active ion transport. a) Schema 
describing routes of Na+, Cl–, and H2O transport and ion transport elements that mediate these flows. 
The luminal surface contains the epithelial Na+ channel (ENaC) and two Cl– channels: cystic fibrosis 
transmembrane regulator (CFTR) and the Ca2+-activated "alternative" Cl– channel (CaCC). CFTR is 
depicted as a Cl– channel and a regulator of ENaC. The basolateral surface contains the Na+/K+ pump, 
the K+ channels, and the loop diuretic sensitive Na+-K+-2Cl– cotransporter. b) Regulation of "excess" 
PCL volume by Na+ absorption and maintenance of PCL at functionally relevant height (7 µm defined 
by the height of extended cilia), by a mix of the Na+ absorption and Cl– secretion. c) Interconversion 
of normal human airway epithelia between absorptive and secretory ion transport modes. When excess 
airway surface liquid (ASL) is present, Na+ absorption mediated via ENaC is dominant (left panel). 
Cl– is absorbed passively via the paracellular path due to the lack of electrochemical driving force 
(DFaCl–) favoring Cl– exit from the cell. In contrast, both the negative apical membrane potential (Va) 
and low intracellular Na+
+
 activity (~20 mM) favour Na+ entry into the cell. When ASL volume is low 
(right panel), ENaC is inhibited, which makes the apical membrane potential more negative and 
generates a driving force for Cl– secretion. Information regarding ASL volume is postulated to be 
"encoded" within the ASL. 
 
Despite the good understanding of the role of the mucus layer as a reservoir, there 
are still surprisingly large gaps in our knowledge of the physiology and biophysics of this 
layer. For example, it is still not clear how this layer is formed in vivo, nor, what are the 
processes that maintain it as a physical layer. Older theories, suggesting that the mucus 
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layer was created by the thixotropic
1
 action of beating cilia, appear to be inaccurate. 
There are very likely important phase transitions that occur as a function of the 
concentration of the gel-forming mucins in ASL. Furthermore, as noted above, it is not 
known what the water storage capacity of the mucin layer is, or the biophysical principles 
that govern the capacity of this layer to absorb or donate liquid. Finally, it’s not yet clear 
how the addition of liquid to airway surfaces increases mucus transport, as the 
biophysical properties of the mucus layer may be less important than the properties of the 
PCL layer. 
The principal determinant of ASL volume is the mass of the salt on the airway 
surface [7]. This fact reflects the highly water permeable nature of the airways epithelium, 
that rapidly restores/maintains ASL volume in a near-isotonic state [8]. The mass of salt I 
the ASL is determined in part by the movement of liquid along epithelial surfaces and in 
part by the active ion transport mechanisms located within that airway region. Recent 
studies have emphasized the importance of the role of the PCL layer volume (height) in 
the maintenance of effective mucus clearance. A useful model for studying PCL 
physiology has been the well-differentiated culture that has had the mucus layer removed 
and a volume of liquid that mimics the properties of PCL placed on its surface. A 
convenient paradigm has been to start experiments with an “excess” of PCL that might 
mimic the height found at the convergence point of two airways. As shown in Figure 3, 
normal human airway epithelia absorb rapidly the excess PCL. But as the PCL layer 
approaches physiology height (7m), active volume absorption ceases and a steady state 
is reached.  
Since the original detection of a raised potential difference (PD) across CF airway 
epithelia in vivo [9], there has been the notion that abnormal electrolyte transport is a key 
                                               
1 Thixotropic, adjective form of thixotropy. Thixotropy is the property of various gels of becoming fluid 
when disturbed (as by shaking) 
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component of CF lung pathogenesis. Early PD studies detected an increase in the 
amiloride
2
-sensitive component of the PD, which suggested an accelerated Na
+
 transport. 
However, the PD measurements also detected a failure to secrete Cl
-
 ions, under basal 
conditions and β-adrenergic3 stimulation, which predicted a second defect [10]. 
Subsequent studies with freshly excised tissues and cultured cells established 
evidence for both Na
+
 transport (upregulated) and Cl
-
 transport (downregulated) defects in 
CF airway epithelia compared with normal cell cultures. It suggested that the CFTR 
protein has a dual function in airway epithelia, i.e., to conduct Cl
-
 ions and to regulate Na
+ 
channel. The absence of CFTR thus causes an up-regulation of Na
+
 absorption through 
ENaC and a failure of Cl
-
 secretion via CFTR. This finding lead to novel therapeutic 
approaches for the CF lung disease. Other than conventional anti-infective and the anti-
inflammatory drugs, the alternative approach is to restore normal ion transport properties 
in CF airway epithelia. Compounds that appear to possess actions that inhibit excessive 
Na
+
 transport and trigger Cl
-
 secretion are nucleoside triphosphates: ATP or UTP. They 
interact with specific receptors on apical epithelial surfaces and activate signaling 
pathways leading to the inhibition of ENaC-mediated Na
+
 absorption and stimulation of 
Ca
2+
-actived Cl
-
 secretion by CaCC in normal and CF airway epithelia [11, 12, 13].  
These cellular responses cause liquid efflux and an increase in ASL volume on CF airway 
epithelia. Similarly, recent data suggest that the local formation of adenosine, a 
dephosphorylation product of ATP interacting with A2B receptors on the apical surface, 
stimulates the activity of CFTR.  
Extracellular nucleoside triphosphates and nucleosides not only participate in 
signaling transduction processes on airway surfaces, but are also actively regulated by 
                                               
2
 Amiloride blocks the epithelial sodium channel (ENaC) thereby inhibiting sodium reabsorption in the 
distal convoluted tubules and collecting ducts in the kidneys. 
 
3 β-adrenergic3 receptors are a class of G protein-coupled receptors.  They stimulate chloride secretion in 
epithelial cells. 
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various enzymes in the ASL. Because ASL ATP and UTP concentrations affect Na
+
 and 
Cl
-
 currents, and thus PCL height, we can think of the biochemical network involving the 
nucleotides (ATP and/or UTP) and their dephosphorylated products as an electronic 
circuit regulating mucociliary clearance. Because the enzymes that catalyze nucleotide 
metabolism have been identified and biochemically characterized, an emerging idea is to 
develop a predictive mathematical model that describes in detail the behavior of this 
biochemical network, and then couple it to a model of ion conductances across the 
epithelium.  
 
 
1.2 OUTLINE    
This dissertation consists of three major parts: the biochemical network model that 
describes the degradation of ATP, the ion and water transport model, and results from 
electrophysiological experiments that are required to couple the two models. Chapter 1 
gives a brief introduction on the physiological background of this problem. Chapter 2, 3 
and 4 cover each of the three topics respectively.  Chapter 2 mostly focuses on the 
biochemical network in a homogenous solution. However, we also discuss some results 
from a spatial model of this network to address some interesting characteristics of ATP 
regulation in the ASL and its potential application in pharmacological drug study of 
cystic fibrosis.
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CHAPTER 2 
EXTRACELULLAR NUCLEOTIDE AND NUCLEOSIDE METABOLISM 
  
2.1   INTRODUCTION 
Mucociliary clearance (MCC) constitutes the first line of defense against the 
establishment of chronic airway infection. Inhaled pathogens are intercepted by a mucin 
layer, maintained above ciliated epithelia by a periciliary (PCL) layer. Together, mucin 
and PCL form the ASL, which is continuously displaced upward by cilia beating activity.  
In lung diseases, like cystic fibrosis and primary cilia dyskinesia, dysfunctional MCC 
leads to severe complications related to airway obstruction and tissue damage by 
inflammatory responses to persistent infections [14,15]. Adenine nucleotides have been 
shown to stimulate all major epithelial functions supporting MCC through cell surface P2 
receptors: electrolyte/ water efflux by ENaC to maintain optimum ASL height [15], 
mucus secretion [16,17] and cilia beating activity [18, 19]. They are secreted by the 
epithelium under basal conditions [20, 21] and at higher rates in response to mechanical 
stress such as pathogen interaction, rhythmic breathing or coughing [21- 24]. Nucleotide-
mediated epithelial responses are terminated by cell surface enzymes converting ATP into 
adenosine [26- 28]. This nucleoside initiates a second wave of signaling through A2B 
receptor-mediated cilia beating [29] and ion/water efflux by the cystic fibrosis 
transmembrane regulator (CFTR) [30]. 
 
 Despite the importance of this regulatory system for airway defenses, it has not 
been possible to design a mathematical model to describe this system due to the 
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unavailability of quantitative information regarding ASL nucleotide concentrations and 
release rates, as well as the kinetic properties of the enzymes and uptake mechanisms. In 
the past decade, extensive work has been conducted to characterize basal and stimulated 
ATP release on human airway epithelia [20, 21, 23-25, 32, 33]. In addition, members from 
all three families of ectoATPases [ecto-nucleoside triphosphate diphosphohydrolases (E-
NTPDases), alkaline phosphatases (APs) and ecto-nucleotide 
pyrophosphatase/phophodiesterases (E-NPPs)] [34,35] have been identified on the apical 
surface of human bronchial epithelial cells [26-28,36-38], along with an ecto-adenylate 
kinase (Ecto-AK; 2ADP ↔ ATP + AMP) [39,40]. The enzymes supporting the conversion 
of AMP to adenosine were identified as ecto 5’-nucleotidase (Ecto 5’-NT) and non-
specific alkaline phosphatase (NS AP) [26], whereas airway adenosine is eliminated by 
adenosine deaminase 1 and concentrative nucleoside transporters (CNT2 and CNT3) [41].  
A mathematical model of nucleotide regulation on the apical surface of human 
airway epithelia was built based on the above empirical data. The kinetic coefficients 
were optimized by fitting the model’s output to experimental parameters of ATP 
metabolism [26,38,40], adenosine/ inosine uptake [41], nucleotide release and cell surface 
concentrations [25,32] . Sensitivity analyses reproduced major aspects of airway 
nucleotide regulation, including the respective contributions of high- and low-affinity 
ectonucleotidases to the regulation of steady-state and transient nucleotide concentration. 
This study provides a first mathematical approach to the investigation of an important 
defense mechanism in human airways.  
 
2.2  METHODS 
Functional Measurements of ATP Levels and Metabolism 
The model was validated by functional assays conducted on polarized primary 
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cultures of human bronchial epithelial cells grown at air-liquid interface, as previously 
described [42]. Steady-state ATP levels were measured by luminometry using soluble 
luciferase or chimeric Staphylococcus
 
aureus protein A-luciferase (SPA-luc) attached to 
antigens on the epithelial surface [32]. The time-courses of ATP metabolism were 
obtained from high-performance liquid chromatography (HPLC) analysis of apical buffer 
samples collected over time after the addition of 1-1000 M ATP to the apical surface 
[27]. The kinetic parameters of airway NS AP for ATP and ADP were obtained as we 
previously described for AMP [26] in the presence of 0.5 mM Ap5A to prevent 
transphosphorylation events through ecto-AK activity [30]. 
 
 
Kinetic Model of Airway ATP /Adenosine Regulation  
This section outlines the theory and methodology behind the mathematical model 
designed to simulate nucleotide regulation on the apical surface of human airway 
epithelia. A biochemical network was derived using quantitative information gathered 
from the literature on nucleotide release [25,32] and metabolism [26-28,36,38] by 
cultured human bronchial epithelial cells (Figure 4). Because UTP levels are about 15% 
 
ATP ADP INOADOAMP
(-)
(-)
Airway surface
Epithelial cells 
(1, 2) (1, 2)
(3)
(3)
(4)
(5) (6)
(7)
 
 
Figure 4: Diagram of nucleotide transport/metabolism on the apical surface of human airway epithelia. 
Released from the epithelium, ATP undergoes a series of dephosphorylation and rephosphorylation 
reactions catalyzed by ectonucleotidases. The end products, adenosine (ADO) and inosine (INO), return 
to the cytosol via concentrative transporters. The model also incorporates feed forward inhibition of 
ADO production by ATP and ADP. (1, 2), E-NTPDases, APs; (3), Ecto-AK; (4), E-NPPs; (5) Ecto 5’-
NT; (6), ADA1; (7) CNT2, CNT3.  
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that of ATP [43] in the ASL, the influence of uridine nucleotides on ATP metabolism was 
considered negligible. Therefore, the reactions supporting ATP dephosphorylation to 
adenosine and adenosine deamination are: 
 
                           ATPADP Pi   (2.1) 
                              ADPAMP Pi   (2.2) 
                              AMPADO Pi   (2.3) 
                              ADO INO   (2.4) 
                               ATP AMP  PPi   (2.5) 
 
Michaelis-Menten kinetics is used to model these reaction rates, in the form:  
                         

reaction rate 
Vmax, j[S]
KM , j  [S]
 (2.6) 
 
 
where [S] is the substrate concentration,  and Vmax,j and KM,j designate the maximum 
reaction velocity and Michaelis constant, respectively. Because several reactions are 
catalyzed by more than one enzyme, the subscript j is used to index the multiple enzymes. 
Adenosine and inosine uptake by CNTs also follows Michaelis-Menten kinetics [41]. In 
contrast, the reversible Ecto-AK reaction:  
                              
                              ATP  AMP 2ADP  (2.7) 
 
 
which involves two substrates, was assumed to follow a Ping-Pong mechanism [44]:  
                     

reaction rate   
Vmax, forward
1 KATP / [ATP] KAMP / [AMP]
- 
Vmax,backward
1 2KADP / [ADP]
 (2.8) 
 
 
The Ping-Pong mechanism is a generalization of Michaelis-Menten kinetics that relies on 
the same underlying assumptions.  
Experimental evidence indicates that ATP and ADP competitively bind to enzymes 
that catalyze AMP dephosphorylation [26,45]. The following equation was used to model 
this effect: 
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-  

reaction rate 
Vmax, j[AMP]
KM , j 1
[ATP]
Ki,ATP

[ADP]
Ki,ADP






 [AMP]
 (2.9) 
 
 
Although it is possible that the inhibition constants Ki,ATP and Ki,ADP may differ for ecto 
5’-NT and NS AP, a single value was assigned for simplicity. 
 The remaining elements to incorporate into the model are the rate of ATP release 
and steady-state ASL nucleotide concentrations. In accordance with experimental 
observations [25], the basal (unstimulated) rate of ATP release (JATP) was considered 
constant. However, one of the functions of nucleotide release is to stimulate fluid efflux, 
which in turn, may affect ASL nucleotide concentrations. Under steady-state conditions, 
while basal release rates do not sustain ATP levels sufficiently high to activate P2 
receptors, the steady-state adenosine level generated from ATP metabolism stimulates 
fluid efflux into the ASL by the A2B receptor-CFTR pathway [30]. The equation was 
therefore derived to take into account time-dependent ASL volume changes during basal 
ATP release. We considered this case in which ATP is released into the ASL layer at a 
rate of JATP molecules per second and then hydrolyzed by enzyme E. The surface area of 
the epithelium is denoted by A, and [E]T represents the surface density of E generally 
expressed in moles/cm
2
. If V indicates the volume, the equation governing ASL ATP 
concentration is: 
                           
dt
dV
V
ATP
ATPK
ATPE
V
AK
V
J
dt
ATPd
M
T
cat
ATP ][
][
][][
][


  (2.10) 
 
 
where the last term in the equation models changes in ATP concentration due to the 
changing volume. The fact that ATP flux and Vmax, designated by kcat (A/V) [E]T, scale 
inversely with volume predicts that steady-state ATP levels are independent of ASL 
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volume. The biochemical steps describing ASL nucleotide metabolism are modeled by 
the equations: 
 

d[ATP]
dt

1
V
JATP 
Vmax
(1) [ATP]
KM
(1)  [ATP]

Vmax
(2) [ATP]
KM
(2)  [ATP]

Vmax
(3) [ATP]
KM
(3)  [ATP]

Vmax
(10)[ATP]
KM
(10)  [ATP]



                      
Vmax, forward
1
KATP
[ATP]

KAMP
[AMP]

Vmax,backward
1
2KADP
[ADP]
 [ATP]
dV
dt



 
          (2.11)

d[ADP]
dt

1
V
Vmax
(1) [ATP]
KM
(1)  [ATP]

Vmax
(2) [ATP]
KM
(2)  [ATP]

Vmax
(3) [ATP]
KM
(3)  [ATP]

Vmax
(4)[ADP]
KM
(4 )  [ADP]

Vmax
(5) [ADP]
KM
(5)  [ADP]



                     
2Vmax, forward
1
KATP
[ATP]

KAMP
[AMP]

2Vmax,backward
1
2KADP
[ADP]
 [ADP]
dV
dt



 
 (2.12)

d[AMP]
dt

1
V
Vmax
(4)[ADP]
KM
(4 )  [ADP]

Vmax
(5) [ADP]
KM
(5)  [ADP]

Vmax
(10)[ATP]
KM
(10)  [ATP]




Vmax, forward
1
KATP
[ATP]

KAMP
[AMP]

Vmax,backward
1
2KADP
[ADP]
                      
Vmax
(6) [AMP]
KM
(6) 1
[ATP]
Ki,1

[ADP]
Ki,2






 [AMP]

Vmax
(7) [AMP]
KM
(7) 1
[ATP]
Ki,1

[ADP]
Ki,2






 [AMP]
                     
Vmax
(8) [AMP]
KM
(8) 1
[ATP]
Ki,1

[ADP]
Ki,2






 [AMP]
 [AMP]
dV
dt



 (2.13)

d[ADO]
dt

1
V

Vmax
(9) [ADO]
KM
(9)  [ADO]

Vt ,1[ADO]
Kt ,1  [ADO]




Vmax
(6) [AMP]
KM
(6) 1
[ATP]
Ki,1

[ADP]
Ki,2






 [AMP]
                     
Vmax
(7) [AMP]
KM
(7) 1
[ATP]
Ki,1

[ADP]
Ki,2






 [AMP]

Vmax
(8) [AMP]
KM
(8) 1
[ATP]
Ki,1

[ADP]
Ki,2






 [AMP]
                      [ADO]
dV
dt



 (2.14)

d[INO]
dt

1
V
Vmax
(9) [ADO]
KM
(9)  [ADO]

Vt ,2[INO]
Kt ,2  [INO]
 [INO]
dV
dt






      (2.15) 
The independence of nucleotide concentrations on ASL volume under steady-state 
conditions, determined by setting time derivates to zero, was verified by simulations and 
functional assays. The model predicts that an increase in ASL volume acutely reduces 
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ATP and ADP concentrations, followed by a rapid return to steady-state levels (Figure 
5A). This model feature was validated experimentally using cultures of human bronchial 
epithelial cells (Figure 5B). Steady-state ATP levels, measured 60 min after the addition 
of 10-500 l phosphate-buffered saline to the apical surface [32], were not affected by 
liquid volume.   
When fitting the model, random sets were generated using a multivariate Gaussian 
distribution with means equal to the experimental data and standard deviations equal to 
25% of the mean. These parameter sets were used as initial guesses in MATLAB 
nonlinear least square routines. After the modeling fitting, the estimated parameter sets 
are collected and residuals are compared (Table 1). A set that corresponds with the 
minimum residual is chosen to be the  best fitting. 
 
 
Figure 5: Comparison of model prediction with experimental measurements for steady state [ATP] and 
[ADO]. (A) Model prediction for steady-state [ATP] and [ADO] with constant JATP before and after 
addition of a 20 l volume to the ASL layer. (B) Measurement of basal [ATP] with SA-luciferase or 
soluble luciferase on human bronchial cultures over a wide range of phosphate-buffered saline (PBS) 
added to the apical surface. 
 
 
Linear Model for the Steady-State Nucleotide Concentrations 
Experimental observations indicated that, under physiological conditions, steady-
state nucleotide concentrations are orders of magnitude lower than the KM values of the 
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enzymatic reactions [25]. Therefore, to a good approximation, the Michaelis-Menten 
reaction rates can be simplified (linearized) as follows:  
-  

V (k )max, j [S]
K (k )M , j  [S]j
 ~
V (k )max, j
K (k )M , jj







[S] P(k )[S]  (2.16) 
 
 
where the parameter P
(k)
 denotes the sum of the ratios of V
(k)
max,j to K
(k)
M,j for all the 
enzymes that catalyze the same reaction. The expressions for adenosine and inosine 
uptake can be simplified in a similar way. Furthermore, model simulations revealed that 
the non-linear parameters, the reversible Ecto-AK reaction given in Eq.(2.9) and the 
inhibition of AMP hydrolysis by ATP and ADP (Table 1), do not significantly affect the 
steady-state behavior of the model (data not shown). They were, therefore, excluded from 
the linear model. Using these simplifications, Eq.(2.11) -(2.15) can be approximated 
under steady-state conditions by the following set of linear algebraic equations: 
                             
 
J - P1 ³[ATP]ss = 0   (2.17) 
 
                     
 
P1 ³[ATP]ss - P2 ³[ADP]ss = 0   (2.18)    
                  
 
P2 ³[ADP]ss - P3 ³[AMP]ss = 0   (2.19) 
 
 
P3 ³[AMP]ss - P4 ³[ADO]ss - U1 ³[ADO]ss = 0   (2.20) 
 
                   
 
P4 ³[ADO]ss - U2 ³[INO]ss = 0   (2.21) 
 
where U1 and U2 result from linearizing the expressions for adenosine (Eq. (2.20)) and 
inosine (Eq. (2.21)) uptake, respectively.  
 
Sensitivity Analysis 
An important tool for analyzing differential equation models of biochemical pathways is 
sensitivity analysis. This technique determines the influence each parameter has on the 
system and identifies which components of the pathway can be perturbed to produce the 
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largest effect. Briefly, if the elements of the vector x(t) are solutions to the model 
equations: 
                             
dx
dt
 f (x,t  ;  p)   (2.22) 
 
where the elements of the vector p are the model parameters, the ratio   
 Si, j (t) 
xi (t)
xi (t)
 p j
p j

Percent change in xi (t) 
Percent change in p j
 (2.23) 
=is used as a measure of the sensitivity of the ith model variable to perturbations in the jth 
parameter value. The sensitivities Si, j (t) are time dependent and require knowledge of the 
quantityxi (t)  p j . The partial derivatives xi (t)  p j satisfy a set of M by N differential 
equations that involve the time-dependent Jacobian of the model equations and the 
quantity   
 
( ),  ; 
i j
f x t t p p . After determining the best parameter set for the non-linear 
model of ASL nucleotide regulation, sensitivity analyses were performed to test the 
importance of high- and low-affinity enzymes on the regulation of transient and steady-
state concentration profiles, as well as the physiological relevance of the feed forward 
inhibition of adenosine production by ATP. 
2. 3  RESULTS 
Analysis of the Linear Steady-State Model 
 We started our investigations using the multi-component model shown in Figure 4 
and described by Eq.(2.11) -(2.15). Experimental measurements were available for all 
model parameters, except for the KM of AMP hydrolysis by Ecto-AK (Eq.(2.8); kf12 in 
Table 1) and inosine uptake. Initially, these were taken as free parameters to fit time-
dependent changes in nucleotide ASL concentrations after the addition of 100 mM ATP. 
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Under these conditions, considerable discrepancies were found between the model 
simulation and experimental data for both transient [Figure 6A] and steady-state [Figure 
6B] concentration profiles.  
 
Figure 6: Model validation of the transient and steady-state concentration profiles generated by the non-
linear model without data fitting. (A) The smooth curves are simulation results and the symbols are 
experimental data for ATP (●), ADP (■), AMP (▲), adenosine (▼) and inosine () concentration obtained 
for buffer samples collected after the addition of 100 M ATP to the apical surface of bronchial epithelial 
cultures. (B) Steady-state ATP, ADP, AMP and adenosine concentrations obtained by functional 
measurements (filled bar ± SEM) and predicted by the equations (empty bars).  
 
 
 The model was considerably improved by using the experimental data 
as initial guesses, then fitted using the nonlinear least square routine of the 
MATLAB software (Mathworks, Natick, MA). This simulation reproduced 
closely the transient (Figure 7A) and steady-state (Figure 7B) concentration 
profiles. Furthermore, among the 14 experimental Vmax, only two remained ≥ 
2-fold different from estimated values: the low-capacity ATPase activity (v1) 
and adenosine deamination (v9) (Table 1). However,  large discrepancy (15-fold) 
persisted between measured and predicted rates of basal ATP release (Table 1). 
Comparable values were obtained by different research groups using various methods 
[23,25,32], thereby ruling out experimental error. On the other hand, if the rate of ATP 
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release was held fixed and the other parameters left free to be determined by fitting the 
data, the model reproduced the transient behavior of the system after the addition of 100 
M ATP (Figure 7C), but not the steady-state concentration profile (Figure 7D).  
 
 
Figure 7: Model validation of the transient and steady-state concentration profiles generated by data fitting 
using the Matlab nonlinear least square program and without (A,B) or with (C,D) a fixed rate of ATP 
release. (A,C) The smooth curves are simulation results and the symbols are experimental data for ATP (●), 
ADP (■), AMP (▲), adenosine (▼) and inosine () concentration obtained for buffer samples collected 
after the addition of 100 M ATP to the apical surface of bronchial epithelial cultures. (B, D) Steady-state 
ATP, ADP, AMP and adenosine concentrations obtained by functional measurements (filled bar ± SEM) and 
predicted by the equations (empty bars).  
 
Model simulations were conducted to test whether the non-linear equations, describing 
ecto-AK (Eq.(2.8)) and the feed forward inhibition of AMP dephosphorylation (Eq.(2.9)), 
influence steady-state nucleotide concentrations. The forward and backward reaction rates  
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of Ecto-AK were approximated based on the 35-fold higher steady-state AMP 
concentration compared to ATP (Table 2), while the inhibition of AMP 
dephosphorylation still followed the nonlinear scheme given by Eq. (2.9). This 
manipulation did not influence the steady-state concentration profile. Therefore, 
we developed an approximate linear model to simulate steady-state nucleotide 
levels and the basal rate of ATP release (Eq. (2.17)-(2.21)). The simulation from 
nonlinear model suggested a minor contribution to the steady state from the 
reversible reaction, the inhibition of ATP and ADP to AMP hydrolysis and the 
reaction of ATP converting to AMP. Therefore these three mechanisms were neglected 
from the linear model.  
We first calculated the reaction rate constants Pi’s and Ui’s in the linear model 
from the experimental measurements of the Michaelis Menten parameters. When these 
rate constants were plugged into the linear equations, this model was also inconsistent 
with the experimental rate of ATP release (Table 2). Then we tried the opposite approach 
by plugging the experimental level of all the metabolites except the unavailable INO level 
into the model and solving for parameter set. The ATP release rate and uptake rates of 
adenosine and inosine are assumed to be constant parameters in this procedure. When we 
used this rate constants derived from solving the linear equation to calculate the inosine 
concentration at steady state, we reached a negative value, which is biologically 
impossible (data not shown). Altogether, these maneuvers suggested that no choice of 
parameter values could capture the empirical data and raised the possibility that the model 
was missing a key component.  
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Reactions Parameters Experimental 
Data 
REF Estimations 
(No ADP-AMP 
release) 
Estimations 
(ADP-AMP release) 
ATP → ADP 
 
 
 
 
 
ADP → AMP 
 
 
 
AMP → ADO 
 
 
 
 
 
ADO → INO 
 
ATP → AMP 
 
ATP + AMP → 2ADP 
 
 
ATP + AMP ← 2ADP 
 
 
ATP release 
ADP release 
AMP release 
 
ADO uptake 
 
INO uptake 
 
 
Ki for ATP 
Ki for ADP 
v1 
k1 
v2 
k2 
v3 
k3 
v4 
k4 
v5 
k5 
v6 
k6 
v7 
k7 
v8 
k8 
v9 
k9 
v10 
k10 
vf11 
kf11 
kf12 
vr12 
kr13 
 
JATP 
JADP 
JAMP 
 
vt1 
kt1 
vt2 
kt2 
 
ki1 
ki2 
2.1 
17 
8.1 
129 
16.8 
405 
1.4 
8 
9.1 
94 
1.8 
14 
4.2 
36 
9.8 
717 
0.8 
25 
0.9 
22 
3.8 
23 
N/A 
1.8 
43 
 
0.0012 
N/A 
N/A 
 
0.45 
17.3 
N/A 
N/A 
 
7 
10 
[38]  
[38] 
[38] 
[38] 
[38] 
[38] 
[38] 
[38] 
[38] 
[38] 
[26] 
[26] 
[26] 
[26] 
[26] 
[26] 
[41] 
[41] 
[36] 
[36] 
[40] 
[40] 
[40] 
[40] 
[40] 
 
[25] 
 
 
 
[41] 
[41] 
 
 
 
[40] 
[40] 
8.2 
9.5 
12.2 
142.8 
23.5 
415.2 
2.4 
6.4 
9.7 
114.0 
2.0 
18.9 
5.6 
43.5 
12.5 
708.1 
0.2 
26.5 
1.2 
10.2 
1.8 
21.6 
20.3 
1.3 
43.9 
 
0.0183 
 
 
 
0.3 
2.8 
 
 
 
64.6 
57.5 
5.1 
23.5 
15.0 
126.5 
22.6 
313.9 
1.5 
4.9 
9.2 
90.6 
2.7 
11.6 
5.3 
34.4 
12.9 
908.5 
0.5 
31.5 
1.4 
15.4 
3.0 
34.6 
29.5 
1.3 
59.0 
 
0.0014 
0.0135 
0.0144 
 
0.3 
1.7 
0.45 
11.6 
 
28.2 
33.1 
 
Table 1: Comparison between parameters of ASL nucleotide release and metabolism functionally 
measured and estimated from the linear model without fitting or including parameters of ADP and AMP 
release. Unknown experimental values are labeled ―N/A‖. The units for Vmax and KM are nmoles.min
-1.ml-
1 and M, REF designates the references. 
 
 
 ATP ADP AMP ADO 
Empirical data 
Linear model 
Linear model with ADP/AMP release 
2.2 
5.2 
5.2 
38.7 
4.4 
54.1 
70.2 
4.6 
112.4 
168 
20.5 
501.5 
 
Table 2: Steady-state nucleotide concentrations calculated from the linear model without or with parameters 
of ADP and AMP release.  
 
Predicted release of ADP and AMP 
 Our current knowledge of nucleotide release mechanisms is limited to ATP 
because the ectonucleotidase inhibitor cocktail [32] interferes with measurements of ADP 
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and AMP by ethenyl derivatization and fluorescence chromatography (Lazarowski, E.R., 
pers. comm.). However, emerging studies suggest that mechanical stimulations induce the 
release of ATP, ADP and AMP through exocytosis as a general mechanism in 
mammalian cells, including polarized epithelia [17, 20]. During maturation, secretory 
vesicles accumulate ATP and UDP-sugars in concentrations up to 50-fold above cytosolic 
concentrations, which are converted to ADP and UDP, and eventually to AMP and UMP 
[47]. Therefore, vesicle fusion to the apical membrane would release ATP, ADP and 
AMP. These observations motivated the addition of terms describing ADP and AMP 
release to the mathematical model. Constant fluxes for ADP and AMP were added to the 
linear equations (Eq. (2.17)-(2.21)) and adjusted so that the model generated steady-state 
concentrations similar to the experimental data (Table 2). With these modifications, the 
model accurately captured the basal rate of ATP release and steady-state nucleotide 
concentrations, except for a two-fold higher adenosine concentration. Estimated release 
rates for ADP (0.013 M.min-1) and AMP (0.014 M.min-1) were ten-fold higher than for 
ATP, which would be consistent with their relative steady-state levels [88]. 
 
Reanalysis of the Full Model 
This multi-enzyme model with nonlinear Michaelis-Menten kinetics (Eq.(2.11) -(2.15)) 
was revisited with the parameters of ADP and AMP release determined above. The new 
model closely reproduced both transient and steady-state behaviors. First, the predicted 
metabolic profile for 100 M ATP followed closely the experimental data, except for a 
slight deviation in adenosine accumulation after 30 min (Figure 8A). This discrepancy is 
explained by the assumption of Michaelis-Menten kinetics, which requires the substrate 
concentration to be higher than the KM of the reaction (Ecto 5’NT; 14 M, Table 1). 
Second, this model eliminated the 15-fold difference between measured and estimated 
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rates of ATP release (Figure 8B). Finally, this model provided the best fit of all Vmax and 
KM values (Table 1), except for 2- to 3-fold differences in the feed-forward inhibition 
constants. Collectively, these data demonstrate that the mathematical model closely 
reproduces the complex biochemical network regulating adenine nucleotides on human 
airway epithelia.   
 
Figure 8: Validation of the transient and steady-state concentration profiles generated by data fitting using 
the non-linear model including parameters of ADP and AMP release. (A) The smooth curves are simulation 
results and the symbols are experimental data for ATP (●), ADP (■), AMP (▲), adenosine (▼) and inosine 
() concentration obtained for buffer samples collected after the addition of 100 M ATP to the apical 
surface of bronchial epithelial cultures. (B) Steady-state ATP, ADP, AMP and adenosine concentrations 
obtained by functional measurements (filled bar ± SEM) and predicted by the equations (empty bars).  
 
Sensitivity Analyses 
The capacity of the computational model to reproduce the non-linear components of ASL 
nucleotide regulation was tested by sensitivity analysis of high-affinity Ecto-AK. Figure 
9A shows that blocking Ecto-AK (vf11, kf11, kf12 vr12 and kr13; Table 1) accelerates 
the metabolism of ATP in the 0.1-1.0 M range, as demonstrated by functional  
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Figure 9: Sensitivity analysis of the non-linear model including ADP and AMP release for low-affinity NS 
AP and high-affinity E-NTPDase 1. (A, C) Time-dependent concentration profiles from 10 M ATP before 
(solid line, filled symbols) and after (dashed line, open symbols) blocking Ecto-AK or NS AP parameters. 
The lines are simulations and the symbols experimental data obtained by monitoring the metabolism of 10 
M ATP on bronchial cultures in the absence/presence of inhibitors of Ecto AK (0.5 mM Ap5A) or NS AP 
(10 mM levamisole) (N = 3; SEM omitted for clarity; , ATP; , ADP; , AMP; , ADO; 
INO, ). The simulations also tested the impact of blocking (B) Ecto-AK or (D) NS AP inhibition on 
steady-state nucleotide concentrations, expressed as fold change after blockage.   
 
assays conducted in the absence or presence of 0.5 mM Ap5A [40]. Accordingly, Ecto-
AK activity is not predicted to influence steady-state nucleotide concentrations (Figure 
9B). These data suggest that the role of airway Ecto-AK would be to prolong P2 receptor-
mediated responses within an optimum range of ATP concentrations [41]. 
 Sensitivity analyses were also conducted to ascertain the contribution of NS AP to 
the regulation of ASL nucleotides. Although considered a low-affinity enzyme (KM > 300 
M) when assayed at pH 9-10 [49,51], NS AP has been shown to exhibit both low (KM > 
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400 M) and high (KM ~ 12-20 M) affinities for adenine nucleotides at pH 7.5 in 
various tissues [52-54], including airway epithelia [26]. We previously determined that 
airway NS AP hydrolyzes AMP with KM values of 36 M and 717 M [26]. Since the 
kinetic parameters of airway NS AP for ATP and ADP were unavailable, we performed 
these experiments on primary cultures of human bronchial epithelial cells, as we 
previously described [26]. Two sets of kinetic parameters were identified for ATP and 
ADP hydrolysis (Table 3), with KM values in the ranges reported for total airway 
ectoATPase (k1 and k3) and ectoADPase (k4 and k5) activities (Table 1). The impact of 
blocking NS AP activity on ASL nucleotide regulation was simulated for a physiological 
ATP concentration (10 M) [55-57] by reducing the fitted rate constants for ATP (v1, v3) 
and ADP (v4, v5) hydrolysis by the VMAX values of NS AP (Table 3) and setting the 
parameters of NS AP for AMP hydrolysis (v7, v8) [26] at zero. Figure 9C shows that 
blocking NS AP reduces the rate of ATP elimination, as well as ADP and AMP 
accumulation, by 2- and 3-fold. A stronger effect is predicted on adenosine production, 
depicted by a 4-fold decrease in accumulation rate and a 2-fold decrease in maximum 
concentration. These simulation data were closely reproduced by functional assays on 
bronchial epithelial cultures performed in the absence/presence of 10 mM levamisole [26] 
(Figure 9C). Furthermore, this sensitivity analysis predicts that NS AP influences steady-
state ADP and AMP, but not ATP or adenosine (Figure 9D). Collectively, sensitivity 
analyses and functional assays suggest that NS AP contributes significantly to the 
regulation of transient and steady-state ASL nucleotide concentrations, with potential 
effects on the amplitude and duration of P1 (adenosine) receptor-mediated responses 
following mechanical stimulation.  
 The relative contribution of NS AP and ecto 5’-NT to the production of airway 
adenosine was investigated by sensitivity analyses comparing time-courses of adenosine 
27 
 
accumulation from 1-1000 M ATP. The simulations were conducted before and after 
blocking the kinetic parameters of Ecto 5’-NT (v6, k6; Table 1) or NS AP as above 
(Figure 9), and validated experimentally by paired functional assays on bronchial 
epithelial cultures before and after inhibiting Ecto 5’-NT (10 mM concanavalin A) 
[26,58]  or NS AP (10 mM levamisole) [26,59] . The simulations closely reproduced the 
adenosine profiles obtained from bronchial cultures, as shown in Figure 10A-C for 0.1-10 
M ATP. These experiments also confirmed that both enzymes contribute significantly to 
the production of ASL adenosine from physiological ATP concentrations locally 
encountered after a mechanical stimulation [55-57]. Interestingly, the rate of adenosine 
accumulation from Ecto 5’-NT, but not from NS AP, decreased with increasing ATP 
concentration, resulting in a reversal of their relative contributions. 
 A mathematical model designed to describe the regulation of adenine nucleotides 
on endothelial cells provided evidence for a physiological role of feed forward inhibition 
by ATP on the regulation of vascular adenosine levels [60,61]. To test this possibility in 
the airways, the above time-courses of adenosine accumulation from ATP were repeated 
before and after blocking the feed forward inhibition constants (ki1, ki2; Table 1). Based 
on the vascular model, the data were first analyzed in terms of initial delay to the 
accumulation of 0.3 M adenosine, which approximates the EC50 of A2B receptors for 
CFTR activation on human bronchial epithelial cells [29,30]. Figure 10C shows that the 
lag phase to 0.3 M adenosine was not affected by feed forward inhibition at 
physiological ATP concentrations (≤ 10 M) [55-57]. Although not functionally relevant 
in the airways, the 5-fold reduction in lag phase predicted for Ecto 5’-NT with 1 mM 
ATP is in agreement with this enzyme’s response on endothelial cells [60,61]. The 
simulations were also analyzed for the impact of feed forward inhibition on the 
conversion rate of AMP to adenosine. The model predicts that Ecto 5’-NT is significantly 
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inhibited by physiological ATP concentrations (1-10 M) [55-57], because blocking feed 
forward inhibition increased the rate of AMP hydrolysis by 3-fold (Figure 10E). This 
regulatory mechanism is expected to considerably affect the overall rate of adenosine 
production on airway epithelia after a mechanical stress, as shown by the significant 
effect on total ectoAMPase activities (Figure 10E). In contrast, NS AP activity was not 
affected by ATP concentrations. This sensitivity analysis demonstrates, for the first time, 
that the feed forward regulation of ASL adenosine is specific for Ecto 5’NT. On the other 
hand, the simulations showed that both enzymes regulate steady-state adenosine levels 
(Figure 10F), in agreement with their relative activities in the presence of 0.1 M ATP 
(Figure 10A). The lack of effect on the steady-state adenosine level suggests an efficient 
regulation by cell surface elimination. Altogether, these sensitivity analyses demonstrate 
that the proposed computerized model reproduces the linear and non-linear components 
of ASL nucleotide regulation, and provides novel information that will improve our 
understanding of nucleotide-mediated signaling in human airways. 
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Figure 10: Relative contribution of Ecto 5’NT and NS AP to airway adenosine regulation. (A-C) Simulated 
(lines) time-courses of adenosine accumulation from 0.1-10 M ATP without/with isolating Ecto 5’-NT or 
NS AP activity by reciprocal blockage. The symbols are experimental data from HPLC analysis of ADO 
accumulation on bronchial epithelial cultures from 1 or 10 M ATP with/without an inhibitor of Ecto5’-NT 
(10 mM concanavalin A) or NS AP (10 mM levamisole). The time-course simulations were analyzed for 
the impact of feed forward inhibition by ATP on (D) the delay to 0.3 M adenosine and (E) the initial linear 
rate of ADO production from AMP. (F) Impact of blocking NS AP or Ecto 5’-NT activity on steady-state 
nucleotide levels (* N = 3-5; SEM < 10% of the mean, omitted for clarity). 
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2. 4  DISCUSSION  
 The importance of understanding the dynamic changes in nucleotide 
concentrations taking place on airway epithelia after a mechanical stimulation is 
highlighted by the pivotal role ascribed to purine signaling in the regulation of bacterial 
clearance [16,19]. The continuous (basal) release of ATP from airway epithelia into the 
ASL [20] constitutes a metabolic source of adenosine [26-28], maintaining baseline MCC 
through A2B receptor-mediated ion/water efflux by CFTR and cilia beating activity 
[25,30]. Mechanical stress, such as physical interaction with a pathogen, recruits 
additional defense mechanisms through enhanced ATP release and P2 receptor-mediated 
ion/water efflux by the Ca
2+
-activated Cl
-
 channels, mucin secretion to confine the 
particle, and accelerated cilia beating activity to clear the infection [14]. The airways 
alertness is then rapidly restored by the conversion of ATP to adenosine. Purine signaling 
on airway epithelia, therefore, represents an exceptional example of the intricate 
relationships that evolved between nucleotide regulation and purinoceptor activation to 
protect the airways against the development of a chronic infection. 
 This study presents the first mathematical model of ASL nucleotide regulation on 
the apical surface of human airway epithelia. The equations incorporate the linear 
reactions mediating the sequential dephosphorylation of ATP to adenosine, the reversible 
Ecto-AK activity, the feed forward inhibition of adenosine production by ATP and ADP, 
adenosine conversion to inosine, ATP release and adenosine/inosine uptake. All kinetic 
parameters were extrapolated from functional experiments conducted on the apical 
surface of polarized primary cultures of human bronchial epithelial cells. The simulations 
closely reproduced the steady-state nucleotide concentrations and the transient 
concentration profile measured on cultured bronchial epithelial cells after the addition of 
100 M ATP. However, regardless of the fitting strategy, a 15-fold difference remained 
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between the simulated and experimental rates of ATP release, suggesting that the model 
was missing a key component. 
 Recent efforts to elucidate the mechanisms of ATP release led to the proposition 
that adenine nucleotides other than ATP are also secreted from mammalian cells [47]. 
Mechanical stress has been shown to stimulate vesicular ATP release in a variety of 
mammalian cells, including endothelial and epithelial cells [17,46-48]. For instance, 
disruption of vesicle trafficking by brefeldin A inhibited basal and mechanically-
stimulated ATP release from oocytes [62]. Secretory vesicles accumulate ATP and UDP-
sugars at concentrations 50-fold higher than in the cytosol [47]. During maturation, they 
are converted to ADP and UDP, respectively, and eventually to AMP and UMP [47]. 
Vesicle fusion to the apical membrane is, therefore, expected to release not only ATP, but 
also ADP and AMP. Accordingly, modification of the model to include parameters of 
ADP and AMP release provided the best fit of experimental transient and steady-state 
concentrations profiles, and resolved the differences between predicted and estimated 
rates of ATP release.  
 The mathematical model reproduced an important property of ASL nucleotide 
regulation, which is the independence of steady-state nucleotide concentrations on 
dynamic changes in ASL volume. A volume doubling, which corresponds to the 
maximum response of the ASL to mechanical stress [23], disrupted the steady-state ATP 
concentration during < 3 min. Hence, the model simulation predicts that a single 
mechanical stimulation will sustain P2 receptor activation during < 3 minutes before 
purinergic signaling returns to baseline A2B receptor-mediated MCC. Since ATP, but not 
adenosine, induces mucin release [63,64], this rapid ―on-and-off‖ switch system may 
represent a protective mechanism against mucin overproduction and airway obstruction. 
In addition, as P2 receptor-mediated MCC constitutes an emergency response to airway 
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insults, the rapid cessation of each signal may represent an evolutionary means to 
optimize the airways alertness to subsequent invasions. 
 The complexity of the multi-enzyme system suggests that several 
ectonucleotidases compete for the same metabolic steps (NS AP: ATP → ADP → AMP; 
E-NTPDase1 or 3: ATP → ADP → AMP: E-NPPs; ATP → AMP) [35]. This apparent 
redundancy may be resolved by sorting the ectonucleotidases in two kinetically-distinct 
groups regulating different nucleotide concentrations: high-affinity (E-NTPDase 1, E-
NPPs, ecto-AK, NS AP) and low-affinity (AP, NTPDase 3, NS AP) [38,65]. Among 
them, the reversible transphosphorylating reaction of ecto-AK (ATP + AMP ↔ 2ADP) 
has been suggested to prolong the effective concentrations of the P2 receptor agonist, 
ATP, on the apical surface of human airway epithelia [40]. This proposition was 
confirmed in the present study by sensitivity analysis and functional assays against 10 M 
ATP. The inhibition of Ecto-AK activity suppressed ATP elimination within 1.0-0.1 M, 
which maximally activates P2Y2 receptors on human airway epithelia [31]. Collectively, 
these findings demonstrate that the computerized model was able to capture the 
contribution of Ecto-AK to the biochemical network regulating ASL nucleotides.  
 Non-specific alkaline phosphatase represents a unique enzyme, exhibiting both 
low (KM > 400 M) and high (KM ~ 12-20 M) affinities for adenine nucleotides when 
assayed at physiological pH [26,52-54]. We previously showed that airway NS AP 
hydrolyzes AMP with KM values of 717 M and 36 M [26]. In order to determine the 
role of NS AP in the regulation of ASL nucleotides, we determined the kinetic parameters 
of NS AP toward ATP and ADP on primary cultures of human bronchial epithelial cells. 
In agreement with the known characteristics of NS AP, two parameter sets were identified 
for each substrate, with low and high affinities, respectively. Based on this information, 
sensitivity analyses were conducted by blocking all kinetic parameters of NS AP for ATP, 
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ADP and AMP, and validated by functional assays conducted with the selective inhibitor, 
levamisole, on primary cultures of human bronchial epithelial cells. The corresponding 
simulation reproduced the impact of NS AP inhibition on the transient concentration 
profile generated by an ATP level (10 M) reached locally in response to mechanical 
stress [55-57]. The elimination of 10 M ATP was reduced by 20%, as previously 
demonstrated with a higher substrate concentration (1 mM ATP) [27]. Altogether, these 
data suggest that NS AP plays a minor role in the regulation of ASL ATP. On the other 
hand, the simulations and experimental data indicated that blocking NS AP causes larger 
perturbations on the transient adenosine profile, with a 4-fold decrease in the 
accumulation rate and a 2-fold decrease in maximum concentration. The lower impact on 
ATP than adenosine is consistent with the biochemical properties of purified NS AP, 
exhibiting relative maximal velocities in the following order: AMP > ADP > ATP 
[49,66]. Altogether, these results suggest that NS AP regulates the amplitude and duration 
of P1 (adenosine) receptor-mediated responses following mechanical stimulation.  
 In the vascular system, the complex purinergic regulation of thrombus formation 
motivated the development of a mathematical model describing the regulation of 
nucleotide metabolism on endothelial cells [60,61]. The vessel walls are exposed 
millimolar ADP and ATP concentrations locally discharged by activated platelets. While 
ADP activates nearby platelets through P2Y1 and P2Y12 receptors, ATP and adenosine 
suppress platelet activation through P2X1 and A2A receptors, respectively [67,68]. Platelet 
aggregation and thrombus formation are regulated by adenine nucleotide metabolism 
taking place on nearby endothelial cells by the coordinated activities of E-NTPDase 1 and 
Ecto 5’-NT [69]. Gordon et al. demonstrated that the dynamic changes in nucleotide 
concentrations taking place on endothelial surfaces exposed to > 100 M nucleotides 
could only be simulated if the model included parameters of feed forward inhibition of 
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adenosine production by ADP [60]. In essence, extensive local nucleotide release, due to 
tissue damage and platelet degranulation, creates a time gap between ADP- and 
adenosine-mediated responses to allow sufficient time to consolidate the thrombus while 
minimizing spread beyond the site of damage. Biochemical assays conducted on purified 
enzyme preparations showed that Ecto 5’-NT is inhibited by ATP and ADP [70,71]. The 
regulation of adenosine on airway epithelial surfaces is further complicated by the 
presence of an additional ectonucleotidases supporting the cell surface conversion of 
AMP to adenosine: NS AP. We therefore tested whether feed forward inhibition plays a 
significant role in the regulation of adenosine by the complex biochemical network of 
airway epithelia. However, since most P2 receptor-mediated responses are initiated by 
ATP, rather than ADP [18], the present study focused on the ability of mechanically-
induced ATP to regulate adenosine production.  
 The computational model and functional assays both demonstrated the existence 
of a significant negative relationship between ATP concentration and adenosine 
accumulation. The time lag required for the accumulation of 0.03 M adenosine, which 
approximates the EC50 of A2B receptors for CFTR activation [29,30], was significantly 
increased by ATP concentrations > 100 M. While these results are consistent with the 
vascular model [60,61], airway epithelial surfaces are not expected to encounter 
nucleotide concentrations above 10 M under normal conditions [55-57]. Possibility 
remains that this regulatory mechanism may become relevant during massive ATP 
release, from extensive epithelial damage or bacterial killing, in chronic lung diseases 
such as emphysema. 
 Feed forward inhibition became physiologically relevant for ASL nucleotide 
regulation when analyzed in terms of the rate of adenosine accumulation. Model 
simulations and experimental data showed that 1-10 M ATP significantly inhibits Ecto 
35 
 
5’-NT activity, as previously reported on airway epithelia [26]. In contrast, NS AP was 
unaffected by ATP concentration on human airway epithelia. The overall effect on ASL 
adenosine regulation was a reversal in the relative contribution of the two enzymes at 
ATP concentrations ≥ 1 M, as the concentration profile for adenosine accumulation 
became dictated primarily by NS AP. These results are in contradiction with the 
previously reported dominance of Ecto 5’-NT established on these epithelial surfaces for 
100 M AMP [26], which did not account for the feed forward inhibition by ATP. The 
present study illustrates the importance of investigating the physiological role of a single 
ectonucleotidase within an integrative setting including all factors regulating ASL 
nucleotides. This feed forward mechanism, in biochemical networks where NS AP is 
absent, may be important to prevent A2B receptor desensitization [72]. On the other hand, 
chronic lung diseases, including cystic fibrosis, chronic pulmonary disease and primary 
ciliary dyskinesia, are characterized by enhanced NS AP activity and expression [27]. The 
lack of feed forward regulation of NS AP may contribute to the vulnerability of the 
airways to the development of chronically-elevated adenosine in pathological conditions 
associated with excessive ATP release, which is known to exacerbate inflammation and 
tissue damage [73].  
 In conclusion, this study provides a robust mathematical model for the regulation 
of two powerful signaling molecules: ATP and adenosine. The model predicts that P2 and 
A2B receptor-mediated epithelial responses will be sequentially activated by an insult, 
according to the relative concentrations of ATP and adenosine within the ASL layer. The 
present study also demonstrates that the physiological importance of a single 
ectonucleotidase may be tissue specific, depending on the biochemical network regulating 
extracellular nucleotides and on the local concentrations encountered under normal and 
pathological conditions. This demonstration constitutes a first step toward the 
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understanding of nucleotide-mediated MCC. In the near future, these equations will be 
refined to include parameters describing the regulation of P2 and P1 receptor activation, 
as well as the epithelial responses supporting bacterial clearance.  
 
2. 5   FUTURE APPLICATION 
 
Layered Structure of Airway Epithelium 
 Under in vivo condition, the airway epithelium in human lung is covered by two 
liquid layers: the periciliary layer (PCL) and the mucus layer (Figure 11). Among them, 
the periciliary layer (PCL) is the closest to the epithelial cell membrane. Nature designs 
the PCL in a way that it has approximately same height of cilia, a hair-like organelle that 
is rooted on epithelial membrane, so that cilia can conduct constant beating in the PCL. 
The force on the tip of cilia transports the mucus layer atop, along with the bacteria 
trapped in the mucus, in an upward motion and eventually out of our body through nose 
and throat. In physiology, the mucus layer and PCL, together, is called airway surface 
liquid, or ASL. 
 
 
Figure 11: Layer structure of airway surface fluid (ASL) in human lungs. ASL is 
composed of two major layers: the mucus layer and the periciliary layer (PCL). PCL 
has similar thickness as cilia, which is about 7 micron. Mucus layer is approximately 
twice as thick as PCL. 
 
37 
 
Epithelial cells are able to secrete enzymes to its membrane, which form a very 
thin layer within PCL (Figure 11). When ATP is released from epithelial cells, it diffuses 
through the enzyme layer first, where it interacts with enzymes and gets hydrolyzed. At 
the same time, some ATP molecules are able to escape and diffuse upward through the 
rest part of PCL and then to mucus layer. When the local concentration of ATP close to 
the epithelial cell membrane becomes less and less, ATP molecules beyond the enzyme 
layer will diffuse downward due to the concentration gradient (Figure 12). 
 
Model Equations 
As diffusion tends to drive ATP and its metabolites away from enzyme layer to 
prevent it from getting degraded, we are interested in how diffusion could possibly affect 
the metabolism of ATP and the metabolites. Therefore we built up a partial differential 
equation system that describes the motion of ATP in the ASL. Because only the total 
amount of enzymes has been measured, and we have no idea about the distribution of 
enzymes at epithelial cell membrane under in vivo conditions, we assume even 
distribution for enzymes in the spatial model. That means the diffusion happens only in 
the vertical direction, or the direction of ASL height. The thickness of different layers in 
this model is specified according to the in vivo measurements [86]. Due to the lack of 
information on thickness of enzyme layer, it is assumed to be 3 m . 
Eq. (2.24) describes the motion of the five species of nucleotides and nucleosides 
in the model. The variable

C  is a vector, representing the concentrations of all the 
metabolites in the ASL. The activity of all the species in the enzyme layer [0  LE] is 
described by reaction-diffusion equation. Reaction diffusion systems are mathematical 
models that describe how the concentration of one or more substances changes under the 
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influence of two processes: chemical reactions in which the substances are converted into 
each other, and diffusion which causes the substances to spread out in space. 
 
 
Figure 2.9: The activities of nucleotides and nucleosides in ASL. 
 
Mathematically, reaction–diffusion systems take the form of semi-linear parabolic 
partial differential equations. In Eq. (2.24), 

DP
2
v
C
y2
 and R(t,
v
C) are related to diffusion 
along the ASL height and reaction in the enzyme layer, respectively.  In the rest of the 
PCL and mucus layer, ATP and its metabolites follow Brownian diffusion. Therefore 
only the diffusion equation is used to describe their motion in these two regions. The 
property of PCL and mucus are quite different from each other. The former is has a 
texture that is similar to water (true?), while the mucus layer is more like gel. The value 
of DP, the diffusion constant in the PCL, was chosen to be the same as the ATP diffusion 
rate in bulk water while its diffusion in mucus layer, DM, was assumed to be 10 times 
slower. The difference between ATP, ADP, AMP, and nucleoside adenosine (ADO) is the 
numbers of phosphate and adenosine (ADO) and inosine (INO) only differ in an amino 
group. Therefore we assume they have the same diffusion coefficient. The model 
equations are:   
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To solve the equations requires the specification of boundary conditions (Eq. 
(2.25)).  The boundary conditions of the equation system are set up in such a way that 
there is constant exchange in epithelial cell membrane describing the release of 
nucleotides and uptake of adenosine (ADO) and inosine (INO).  At the other end of 
boundary, i.e., the surface of ASL, zero flux is assumed. We also assume continuous flux 
between each two of the three layers. The initial condition is defined according to the 
situation we want to simulate. 
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Numerical Methods 
Operator-Splitting method is a common way to numerically solve 
reaction/convection diffusion equations, where reaction/convective and diffusive forces 
are accounted for in separate sub-steps. It is widely used in solving initial value problems 
for partial differential equations. That involves more than one operator on the right-hand 
side of the equation. We tried to use the Strang Operator Splitting Method, which is a 
second order numerical scheme (for details, see Appendix 1). Due to the discontinuity of 
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the reaction term along y axis, the noise around discontinuity gets larger with time and 
eventually grows unbounded. To minimize the noise, we have to start with a really small 
delta t or big delta x. Small time steps result in a fairly big matrix and time-consuming 
matrix operation. Big space steps lead to rough lattice and less information about the 
spatial distribution of nucleotide and nucleoside concentrations. However, the diffusion 
model doesn’t favor a rough lattice. If we consider a 21 microns (m) height for ASL and 
the enzyme layer is only a couple of microns, the size of grid can not exceed 1 micron. 
This results in slow computation. Meanwhile, the nonlinearity of the boundary condition 
for adenosine and inosine uptake makes the Strang Splitting Method less applicable to our 
problem.   
The deficiency of Splitting Method led us to try other numerical methods for 
solving reaction-diffusion equations. We switched to a Finite Element Method, which is a 
method for solving the equations by approximating continuous quantities, such as the 
flux, at discrete points, regularly spaced on a grid or mesh. Because finite element 
methods can be adapted to problems of great complexity and unusual geometry, they are 
an extremely powerful tool in the solution of important problems in heat transfer, fluid 
mechanics, and mechanical systems. We use a modeling package called COMSOL 
Multiphysics (formerly FEMLAB) to solve the reaction-diffusion equation system. 
COMSOL Multiphysics is a software for solving different types of PDE’s with finite 
element method in conjunction with adaptive meshing and error control as well as with a 
variety of numerical solvers, which allows us to use really fine grid in the enzyme layer 
and rougher grid in other regions.   
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Justification of Model Simplification for the in vitro Experiments 
 
The in vivo studies showed that most of enzymes that catalyze nucleotide metabolism 
were localized at the surface of epithelial cells in a layer about two microns high. 
Considering the height of airway surface liquid (7-21 microns 86), which is about 10 to 
20 times higher, it is reasonable to expect the existence of vertical gradients in [NT/NS]. 
As the diffusion constant of the molecules also determines if a spatial model is needed, 
we estimated the time required for an ATP molecule to diffuse across the ASL. Table 3 
shows various diffusion coefficients for a ATP molecule in different media. As can be 
seen from Table 3, ATP diffuses in endothelium-fluid interface from pig aortic 
endothelial cells at a slightly slower rate than it does in bulk water. For a medium with 
higher viscosity similar to the cytoplasm, the speed is reduced by half. This means the 
speed for a single ATP molecule to diffuse in the PCL is on the order of 10
-6
 cm
2
.sec
-1
. 
Because no one has ever measured ATP diffusion in the mucus layer, we first consider 
the case in which ATP diffuses equally fast in mucus as in PCL. By the relation T~O 
(L
2
/D), the time it takes to diffuse from the cell membrane to the surface of ASL could be 
estimated to be a couple of seconds. Compared to the time for a pharmacological dose of 
ATP (100m) to hydrolyze in ASL, which is about 10 seconds, the ASL can be 
considered a well-mixed solution and diffusion in this case is neglectible.  
Media in which ATP diffuses 
Diffusion Coefficients 
(cm
2
/sec) 
References 
Cytoplasm 1.5 x 10-6 [74] 
Bulk water 3x10-6 [75] 
Endothelium-fluid interface from pig 
aortic endothelial cells 
2.36x10-6 [76] 
Table 3: Diffusion constants of ATP in different media 
 
We then considered the situation in which ATP diffuses at a different rate than it 
does in the PCL. Considering the mucus layer is similar to gel, it is very likely the ATP 
diffuses slower in this layer. We varied the diffusion rate DM compared to DP, the 
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diffusion in PCL and observed the behavior of the averaged ATP concentration in ASL 
shown in Figure 13. As we slow down the diffusion of ATP in mucus layer, the time for 
ATP to reach the steady state becomes longer. However, not until the diffusion in mucus 
layer is 100 times slower than that of PCL, does the average ATP level in ASL show 
much of a difference. This simulation, along with the calculation earlier, provides strong 
justification for neglecting diffusion in the in vitro experiments we are about to model. In 
those experiments, the mucus layer was removed for the convenience of measuring the 
ATP level. With the presence of only the PCL, the media can be considered as well stired 
solution and only enzyme reactions are necessary to describe the dynamics of ATP and its 
metabolites. 
 
Figure 13: The averaged ATP concentration in ASL when varying 
the diffusion rate in mucus layer DM with respect to the diffusion 
rate in PCL DP. The initial condition here is zero for all the 
metabolites. 
 
 
 
Simulation for Aerosol Delivery 
 
 One of the future applications for the ATP regulation model is to study the aerosol 
drug delivery to the airway of CF lungs. However, one symptom of CF is the 
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accumulation of mucus layer due to the infection and inflammation. In this case, the 
mucus layer is so thick that diffusion will affect the ATP delivery to the airway surface 
and eventually to the interaction with membrane receptors. The validation of ATP 
regulation model without spatial consideration enables us to use it as the reaction term in 
the spatial model we derived earlier. The initial condition here is assumed to be a step 
function representing a layer of ATP at the ASL surface and steady state elsewhere. To 
minimize the numerical error introduced by the discontinuity in the initial condition, we 
use the function flc2hs in COMSOL Multiphysics to smooth out the jump (Figure 14).   
 
 
 
Figure 14: Initial condition of aerosol ATP delivery to the ASL. flc2hs is a 
smoothed Heaviside function with a continuous second derivative. y=flc2h 
(x,scale) approximates the logical expression y=(x>0) smoothing the 
transition within the interval –scale<x<scale. 
 
We numerically solve the equations and calculated the local [ATP] at the 
epithelial membrane where receptors locate. Figure 15 shows that with high mucus heigt, 
ATP is diluted in the larger volume so the [ATP] at cell surface is too low to activate the 
receptor (The effective range of activation is 1uM to 100nM). This simulation will be 
very helpful for studying the effective dose of ATP when designing the inhaling drugs for 
CF.   
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Figure 15: The local ATP concentration at epithelial cell membrane 
numerically solved from the partial differential equation system. The three 
curves represent the numerical solution when we vary the ASL thickness while 
keeping the PCL height fixed.  
 
 
  
 
 
 CHAPTER 3 
ION/WATER TRANSPORT MODEL 
 
3.1  INTRODUCTION 
Epithelial cells make up the lining of the lungs, pancreas, liver, digestive tract and 
reproductive system, and are also found in the sweat glands and sinuses. As mentioned 
earlier, one of the symptoms of CF is to have salty sweat due to the impaired salt 
absorption in the sweat dust, caused by the absence or malfunction of CFTR Cl
-
 channel 
in the apical membrane of dust cells [77]. One of many treatments for CF is saline 
inhalation. Two studies published by Donaldson and Boucher et al. [78] reported that CF 
patients who inhaled hypertonic saline solution at least twice a day were hospitalized half 
as often for lung problems and showed significantly improved mucus clearance.  
Hypertonic saline increases the ion gradient in the ASL and therefore leads to re-
hydration of the airway surface. The potential therapeutic drug we are interested in, ATP, 
restores the ASL through a different mechanism but with same result. ATP binds to 
membrane- bound receptors and activates a second chloride secretion pathway by 
opening Calcium-activated Chloride Channel (CaCC). This mechanism also results in an 
enhanced ion gradient in the airway surface and contributes to the re-hydration of the 
ASL. 
The balance of airway surface liquid across the epithelial cell membrane involves the 
complicated interactions of various transport processes. The three major types of transport 
processes in this system are passive diffusion down electrochemical gradients, 
cotransport, and active transport, which consumes energy. These transport processes are
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inter-related through direct or indirect ways. They act in concert to produce a strongly 
coupled and highly nonlinear system. Therefore, to understand this system requires 
mathematical modeling. 
We built a computational model based on a model for the epithelium of dog trachea 
proposed by Novotny and Jakobsson [79,80]. We have converted the original ion and 
water transport model of Novotny et al. into MatLab and re-set the input parameters to 
match the data from human bronchial epithelial cells reported by Willumsen et al. [81-
85]. To humanize the system, basolateral membrane chloride channels were included in 
the model.  
 
3.2  MATHEMATICAL EQUATIONS 
 
 
 
 
Figure 16: The transport processes in human airway epithelium  
 
 
The model of human airway epithelium is composed of three compartments: the 
airway surface, intracellular region and basolateral region (Figure 16). Transport 
processes across the apical membrane are characterized by passive sodium and chloride 
movement. The basolateral membrane contains passive potassium and chloride transport, 
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along with active sodium-potassium transport and sodium-potassium-chloride cotransport. 
Both membranes are permeable to water except the paracellular pathway, which only 
transports salt. 
 Passive ion transport not only depends on concentration gradients, but also the 
membrane potential difference and therefore is considered eletrodiffusion.  To model this 
effect, we used the Goldman-Hodgkin-Katz equation (Eq (3.1)), which describes the 
current produced by an ion species moving from compartment x to y. The current 
depends on the transmembrane potential Vm, the concentrations in each compartment (Ci,x 
and Ci,y), the permeability of the membrane to this ion (Pi), and the absolute temperature. 
This formula also has several constants such as the valence of ion zi, the Faraday constant 
F and the ideal gas constant R. The ion flux is: 
-  
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The flow of water only depends on the ion gradients and transmembrane permeability to 
water molecules. Therefore the mathematical representation of water flux takes a simple 
form as in Eq. (3.2).  
                   JH2O,xy  PH2O Ci,x
i
  Ci,y
i





 (3.2) 
 
 
where the 
i
xiC ,  and
i
yiC , , are total ion concentrations including the impermeant 
anions in the two compartments. The active transport of sodium and potassium through 
energy-dependent pumps is modeled according to Michaelis-Menten kinetics with a pump 
ratio of three sodium ions per two potassium ions. A term was included to represent the 
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dependence of the pump on membrane potential (5  10-3 Vm,B +1.25). This term was 
derived from the pump reversal potential. This leads to the following expressions for 
active ion fluxes: 
J pump,basocell  J pump,max
[Na ]cell
[Na ]cell K pump,Na






3
[K  ]baso
[K  ]baso K pump,K






2
510
3
Vm,B 1.25              (3.3) 
Jpump,Na,basocell  3Jpump,basocell                                                             (3.4) 
Jpump,K ,cellbaso  2Jpump,basocell                                                               (3.5) 
 
The flux through cotransporter was modeled according to Michaelis Menten 
theory (Eq. (3.6)) as well. Jcot,max is the maximum  ionic flux through the cotransporter (in 
mol.m
-2
.s
-1
). The cotransporter ratio is one sodium ion to one potassium ion to two 
chloride ions. Therefore the ion flux through this pathway remains electro-neutral at all 
times.  The flux through the cotransporter is:  
Jcot,xy  Jcot,max
[Na ]x
[Na ]x  Kcot,Na

[K  ]x
[K  ]x  Kcot,K

[Cl ]x
[Cl ]x  Kcot,Cl ,1

[Cl ]x
[Cl ]x  Kcot,Cl ,2



                       
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
[K  ]y
[K  ]y  Kcot,K

[Cl ]y
[Cl ]y  Kcot,Cl ,1

[Cl ]y
[Cl ]y  Kcot,Cl ,2
 



  (3.6) 
 
 The rate of change of the ion concentrations in each compartment is given by the 
sum of the fluxes into that compartment. For example, the rate equation for sodium 
concentration in cytoplasm is described by Eq (3.7). where caNapassJ ,,  and cbNapassJ ,, are 
passive sodium flux from apical and basolateral regions, while cbNapumpJ ,,3  and 
cbJ cot, are active transport and cotransport sodium fluxes, respectively. The intracellular 
cell volume is included in the equation to account for dilution effects caused by the water 
flux.  
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d[Na ]c
dt

1
Volc
J pass,Na,ac  J pass,Na,bc  3J pump,Na,bc  Jcot,bc 
dVolc
dt
[Na ]c




   (3.7) 
 
 
Following the same consideration, we build up a system of equations, which describes the 
ion concentrations and volume in each compartment. A complete list of equations in the 
model is shown in Appendix II. 
 The relaxation times for different process in this model are quite different from 
each other. The fastest time scale in the system is that for the membrane potential to 
respond to changes in ion concentration. The membrane potential responds with a 
characteristic time on the order of milliseconds determined by the resistance-capacitance 
time constant of the membrane. The time scale for water movement is slightly faster than 
1 second and that for changes in ion concentrations is on the order of tens of seconds. 
Therefore the system is stiff. We used ode15s, the stiff ODE solver in MATALB to 
numerically solve the system. 
At equilibrium, the transmembrane currents satisfy Kirchhoffs loop and node laws, 
such that if the cell were represented by the electrical circuit in Figure 17, then at any 
junction of the circuit the algebraic sum of the currents must be zero (Eq. (3.8)). In this 
figure, IA, IB and IP  are the currents across the apical membrane (positive into the cell), 
the basolateral membrane (positive into the cell), and the paracellular pathway (positive 
toward basolateral surface), respectively. Vm,A, and Vm,P are the apical  and transepithelial 
membrane potentials referenced to the mucosal surface. Vm,B is the basolateral membrane 
potential referenced to the submucosal mucosal surface. 
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Figure 17: voltage-clamp circuit 
representing the equilibrium state 
of transmembrane currents.                               
 
                           
Ia (Vm,A ) I p (Vm,P )  0
Ib (Vm,B ) I p (Vm,P )  0
Vm,P Vm,A Vm,B





  (3.8) 
 
 
At each time step t, we first solve the nonlinear equation system (Eq (3.8)) for the 
equilibrium state of membrane voltages based on the ion gradients and membrane 
potentials from previous time step. These new values are then used as constants in the 
equations describing the rate of change in ion concentrations and volumes. We make sure 
the units of the fluxes in the equations are consistent. All fluxes, amounts, and volumes 
were normalized to the epithelial surface area. Fluxes were in units of moles per second 
per square meter, amounts in each compartment in moles per square meter, and volumes 
of each compartment in cubic meters per square meter.  The equilibrium value for apical 
volume per surface area was chosen to be 7 m, so that the apical fluid has a height equal 
to the length of the cilia [86,87]. For cell, the equilibrium cell volume per surface area 
was chosen to be 20 m, the volume of the cell if it were cylindrical with dimensions 
shown in electron micrographs [86,87] . 
 Our strategy is to benchmark the modified Novotny model of ion and water fluxes 
without including nucleotide regulation. In the absence of such regulation, the Novotny 
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model leads to a state of either complete absorption or unbounded increase in the ASL. 
Although the former has been observed from experiment, the unbounded ASL volume is 
an unphysiological feature. To overcome this effect, Novotny added volume regulation to 
the permeability of the apical membrane Cl
-
channel and to the maximum flux of the 
basolateral membrane cotransporter. Unfortunately, they did not specify a mechanism for 
how the channels and transporters could detect apical and cell volumes and assumed a 
linear coupling to the volume with prescribed upper and lower bounds on the 
permeability and maximum flux. In Chapter 4, we are going to address this problem and 
assume a more realistic nonlinear coupling that does not require specifying artificial 
upper and lower bounds. The ultimate goal is to develop a model that is capable of 
homeostatic regulation by coupling the ion and water flux model to the nucleotide 
regulation model. 
 
3.3  PARAMETER ESTIMATION 
 
The model described above is initial-condition-dependent, meaning that varying the 
initial ion concentrations in each compartment will produce different steady state 
concentrations, volumes and membrane potential. Mathematical analyses revealed that 
this feature is a consequence of the quasi-steady state approximation used for the 
membrane potential. Therefore, we searched for parameter sets that are biologically 
meaningful and produce steady state that is consistent with the experimental observations. 
We fixed the apical and intracellular volumes and ran the simulation to steady state. 
If the steady state is close to the experimental observations, we then let the volume 
change as a result of concentration gradients. The ion channel permeabilities (Table 4) 
were collected from literature [81-85] on human epithelium. When these values were 
used in the simulations, the model produced discrepancies in the steady state of ions and 
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membrane potentials (Figure 18A). Therefore, we optimized the permeabilities such that 
the model produced steady state that matches the experimental observations (Figure 18B, 
Table 5). 
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Figure 3.3:  Comparison of the in vivo measurements (black) and simulation results (red) for ion 
concentrations and membrane potentials before (A) and after (B) the parameter estimation. 
 
 
As shown in Table 5, the parameter estimation produces a set of ion concentrations 
and membrane potentials that has smaller difference from the in vivo measurements. 
There is significant decrease in the discrepancies in the apical chloride concentration and 
basolateral membrane potential. However, the apical sodium concentration remains 16% 
lower than the in vivo condition, despite a small improvement after the estimation. On the 
other hand, the differences of the estimated permeabilities (Table 4) and in vivo 
measurement are all less than 2 folds, suggesting the model equations do not have major 
defects. It is well known that the movement of chloride across the apical membrane 
involves the CFTR Cl
–
 channel; however, conductive pathways for Cl
–
 movement across 
the basolateral membrane have been little studied. Willumsen et al. [84] had found out 
that Cl- transport across the basolateral membrane in the CF epithelium occurs mainly 
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through the bumetanide
4
-sensitive cotransport system but also through a Cl- conductance, 
which suggested that a chloride channel is available to the CF airways. We took this into 
consideration and estimated this permeability along with other parameters. The estimated 
basolateral chloride permeability is 3.5×10
-8 
m/s, which is slightly smaller than the apical 
peramebilty to Cl
-
. We will compare this estimation with experimental measurements 
when it is available.  
Apical Membrane           
(10-8 m/s) 
Basolateral Membrane        
(10-8 m/s) 
Paracellular Membrane          
(10-8 m/s) 
 Exp. Opt.  Exp. Opt.  Exp. Opt. 
PNa,a 1.60 1.30  PNa,b 0 0 PNa,p 1.20 1.41 
P
K,a
 0 0 P
K,b
 10.5 9.98  P
K,p
 3.14 3.08 
P
Cl,a
 2.60 4.19  PCl,b 0 3.50  PCl,p 1.20 1.00 
P
H2O,a
 8650 10200 P
H2O,b
 8650 7940 P
H2O,p
 0 0 
Table 4: Comparison of in vivo measurements of membrane permeabilities to ions and water with estimated 
values. 
 
 
 Airway Surface Cytoplasm Basolateral Region 
 Exp. Opt. Exp. Opt. Exp. Opt. 
[Na+] 120 mM 101 mM 20 mM 23 mM 140 mM 149 mM 
[K+] 20 mM 24 mM 100 mM 84 mM 5 mM 5.4 mM 
[Cl-] 125 mM 123 mM 40 mM 41 mM 105 mM 116 mM 
Vm -26 mV -24 mV  -36 mV -41 mV 
Table 5: Comparison of variables at steady state before and after parameter estimation. 
 
 
 
3.4  MODEL VALIDATION 
 
We then validated the model by testing it against the in vitro experiments [81-85], in 
which the salt concentrations in bilateral compartments were perturbed. Data from human 
                                               
4
 Bumtanide is a potent diuretic that used to inhibit the Na
+
-K
+
-2Cl  cotransporter. 
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nasal epithelial cells were chosen because there are little experimental measurements 
from human bronchial cell available. The nasal membrane permeabilities to ions are also 
very similar to bronchial cells. All of these the experiment was conducted using an 
Ussing chamber setup so that both the apical and basolateral volumes are fixed. So when 
modeling the experiments, we set these two parameters constants and only change the 
initial condition of the ions in different compartments. Shown in Table 6 is the 
comparison of the measurements from one experiment [82] and the simulation results 
from the model. In this experiment [82], apical addition of amiloride (10
-4
M) 
hyperpolarized the apical membrane potentials and decreased transepithelial current. The 
dose used for amiloride (10
-4
M) has been tested to able to block nearly 100% of the 
sodium flux across the apical membrane on the area of the cell culture. To simulate this 
condition, we set the apical sodium permeability to zero and ran the model to steady state. 
Our model successfully predicted the trend of change in membrane potentials (Vm,A, 
Vm,B) and transmembrane short current (Ieq) after the blocking of apical sodium channel.  
 
 
 
Vm,A 
(mV) 
Vm,B       
(mV) 
Ieq
                        
(A/cm
2
) 
Exp. 
Control -25.9 -37.7 -38.7 
Amiloride -36.6 -41.8 -14.8 
Sim. 
Control -31.6 -50.0 -28.9 
Amiloride -60.0 -66.2 -14.6 
Table 6: Experimental observations and numerical simulation using the ion water transport model in the 
experiment where apical sodium is blocked by amiloride.  
 
 
We then started from the model from steady state and allowed the volumes in 
apical and cytoplasm region vary. Without any regulation mechanisms in the model, the 
simulation results shows a decreasing apical volume (Figure 19), which agrees with the in 
vivo observation of un-regulated human airway [88]. Due to the increased ion 
concentration inside the cell, its volume in the increases without bound in the simulation.  
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In reality, the cell couldn’t grow forever. At a certain volume, the surface tension on the 
cell membrane fails to hold the cytoplasmic solution and the cell lyses. However, it is 
very likely that the cell volume can be regulated and kept under control when the airway 
surface liquid is subject to the ATP regulation. 
 
 
 
Figure 19: Simulation of ATP depletion fin the airway. The system was started 
from the steady state that is generated by estimated parameter set. The initial 
volumes for apical fluid and cytoplasm are 7 and 20 m per surface area. The 
apical volume decreases to zero within 100 minutes while the volume of 
epithelial cell tends to grow without bound. 
 
  
3.5   CONCLUSION 
 
The ion/water transport model was based on the physiological theory of ion/water 
transport. The procedure used to perform parameter estimation is very similar to that of 
ATP regulation model. We used the measure parameter values as initial guesses and 
searched for a set of parameters that could produce the best fit for the model compared to 
the resting level of ion concentrationsand membrane potentials in the different 
compartments of airway epithelium.  The positive prediction of the model, i.e., the 
blocking of apical sodium channel and test of default state without any regulation both 
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suggest that the ion/water model accurately captures key features of ion and water 
movement in the airway epithelium and therefore serves as a good model for integration 
with the ATP regulation model.  
  
 
CHAPTER 4 
AIRWAY SURFACE LIQUID REGULATION 
 
In this chapter, we focus on studying the signaling pathways initiated by ATP and 
UTP in epithelial cytoplasm. A series of experiments designed to investigate different 
pathways are performed to show how triphosphate nucleotides (ATP and UTP) and their 
metabolite might, by up-regulating chloride secretion to the airway surface and inhibiting 
absorption of sodium ions back to cytoplasm, be potential therapeutic targets.  
 
 
4.1  INTRODUCTION  
 
The pathogenesis of cystic fibrosis is very complicated. As described in earlier 
chapters, it is characterized by abnormal regulation of the airway surface liquid (ASL).  
The results are achieved by the dual effects of down-regulation of chloride secretion due 
to the mutations in cystic fibrosis transmembrane conductance regulator (CFTR) as a 
chloride channel and hyper-absorption of epithelial sodium ions. Further experimental 
evidence showed that there is a second chloride channel in the apical membrane of airway 
epithelia, which is regulated by increases in intracellular free calcium (Ca
2+
i) [11-13]. 
There is experimental evidence showing the release of triphosphate nucleotides to the 
airway under normal condition. Along with their metabolites, they are able to initiate the 
autocrine and paracrine regulation on ion transport [90-92]. 
There are two major signaling pathways induced by ATP in normal epithelium 
(Figure 20). Intracellular ATP are secreted in response to diverse stimuli (local stress, 
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addendum) and are hydrolyzed by ecto-nucleotidases and other enzymes on airway 
epithelium to adenosine  (ADO) and inosine (INO), which are taken back into the 
cytoplasm by transporter proteins (see  
 
  
Figure 20: The signaling pathways activated by ATP and adenosine in the normal and CF human epithelia. 
A describes the P2Y2 receptor-dependent pathway activated by ATP or UTP. B is the pathway activated by 
binding of adeosine to receptor A2b. C combines the two pathways with nucleotides and nucleosides 
metabolism in the airway surface. D represents the signaling pathway in CF human epithelium. 
 
Chapter 2). While on the airway surface, ATP binds to the purinergic receptor P2Y2-R, 
which is a G-protein-coupled (Gq) receptor and activates its downstream target 
phospholipase C (PLC). Activated PLC hydrolyzes the membrane lipid 
phosphatidylinositol 4, 5-biosphosphate (PIP2), producing inositol 1,4,5-trisphossphate 
(IP3) and diacylglycerol (DAG). IP3 is water-soluble and diffuses through the cytoplasm 
to the endoplasmic reticulum (ER), where it binds to and opens a channel that releases 
calcium from stores inside the ER. A calcium-sensitive chloride channel (CaCC) is then 
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activated and transports Cl
-
 ions from the cytoplasm to apical region. DAG, the other 
product of PIP2 hydrolysis, interacts with both calcium and the protein kinase C (PKC) 
and mediates the chloride current through CFTR. This is the first pathway that not only 
up-regulates apical chloride currents by separate routes from PLC activation, but also 
inhibits ENaC due to the decrease in PIP2 concentration [93-95]. The second pathway is 
initiated by adenosine (ADO) binding to the G-protein-coupled receptor A2b. This 
receptor activates adenylyl cyclase (AC), which in turn raises the local concentration of 
intracellular cyclic-AMP (cAMPi). cAMPi activates protein kinase A (PKA), which by 
phosphorylation activates CFTR and inactivates the epithelial Na
+
 channel (ENaC) [30]. 
There is evidence showing that activation of the epithelial Na
+ 
channel (ENaC) requires 
CFTR Cl
-
 channel function [96]. 
In CF airway epithelium, both the regulation of CFTR through PKC-dependent and 
cAMPi-dependent pathways fail due to a lack of functional CFTR in apical membrane. 
However, the pathway of CaCC activation and ENaC remains intact and thus becomes a 
viable target for CF therapy. The regulation on these two types of ion channels by 
extracellular nucleotides and their metabolites has been shown to help recovery of the 
airway surface liquid (ASL) [97].  The signaling pathways acts like a link that ties 
extracellular nucleoti(si)des metabolism and the change of ion and water flow together. 
Therefore it is very important to study in detail the regulationof this pathway to enable the 
coupling of the two mathematical models described in the previous chapters.       
Many previous studies have focused on this area. Paradiso and Boucher investigated 
[Ca
2+
i] release and influx in polarized human nasal epithelial monolayers using ATP 
administration to stimulate P2 purinoreceptors [98]. In Ca
2+
-containing NaCl ringer 
solutions, ATP added to either the mucosal or serosal side induced an instant peak in 
[Ca
2+
i]. The intracellular calcium concentration then gradually decreased back to near the 
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basal levels. Ca
2+
 signaling was also studied in normal and CF human bronchial epithelial 
(HBE) by UTP and a similar intracellular calcium response was reported [99]. Cystic 
fibrosis airway epithelial Ca
2+
i signaling: the mechanism for the larger agonist-mediated 
Ca
2+
i signals in human cystic fibrosis airway epithelia. 
The up-regulation of CaCC and down-regulation of ENaC have been studied 
together and separately in recent years. Mason et al. [100] studied the transepithelial short 
circuit current (Isc), which reflects the regulation of both CaCC and ENaC in human 
normal and CF airway epithelium and presented rpresentative tracings of the effect on Isc 
of extracellular ATP applied to the apical or basolateral membrane. A study on the 
regulation of CaCC alone was conducted using the same cultures and pretreating the cells 
with amiloride to block ENaC. Meausurements of the chloride current through CaCC 
resembled the Ca
2+
i response induced by extracellular ATP in either of the compartments. 
These two observations provide information on the individual responses of CaCC and 
ENaC. Later, measurements of the response for CaCC to UTP were reported by Tarran et 
al. [97], which showed a similar response to that of ATP but a bigger response in CF than 
normal murine tracheal epithelial (MTE) monolayers. This paper also showed evidence 
that CaCC plays a role in regulating ASL height in response to released agonists (e.g., 
mucosal nucleotides).  
Despite a lot of research on signaling pathways in HNE cells, there is little work on 
HBE cells. Because our extracellular nucleotide and nucleoside metabolism model 
(Chapter 2) was built based on the measurements from HBE cells, we decided to use 
traditional bioelectrode techniques, i.e. modified profusion Ussing chamber experiments, 
to investigate ion transport in these cells. And we used HBE cells from CF patients so that 
CaCC (Cl
-
 current) and ENaC (Na
+
 current) pathways could be studied individually 
without any effect on Isc from CFTR. 
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4.2 MICROELETRODE STUDIES 
 
 
To study how ATP affects ion and water flow across the membrane of epithelial 
cells, we designed a series of in vitro eletrophysiological experiments to measure the 
regulation of ATP on the Calcium Activated Chloride Chanel (CaCC) and Epithelial Na 
Channel (EnaC) individually. Initially, we wanted to qualitatively learn how ATP 
regulates these two channels. That is, how differently the channels respond to ATP, the 
time span of each response and how sensitive the channels are to an increasing dose of 
ATP. After more information was gathered, we studied ATP regulation quantitatively by 
measuring the dose response curves of ATP on the channels. These measurements 
characterize the interaction of ATP and mucosal membrane receptors and the signaling 
pathways they initiate. Therefore, this information is essential for integrating the 
biochemical network model and the ion/water flux model.  
 
 
 
4.2.1 TISSUE CULTURING AND PREPARATION 
 
 
 All the cells used were CF bronchial epithelial cells. Bronchial specimens were 
obtained from CF subjects and removed for clinical reasons. All procedures were 
approved by the University of North Carolina Committee for the Protection of the Rights 
of Human Subjects.  
 
Detachment from specimen/Thawing and plating  
In brief, cells were detached from freshly resected specimens by incubation at 
40
o
C in modified Eagle's medium (MEM) containing 0.1% Protease 14 (Sigma Chemical 
Co., St. Louis, MO) and 100 Mg/ml DNAase (Sigma Chemical Co.). Cells were isolated 
after 24-48 h by centrifugation (800 g), protease neutralized (10% FBS), after which the 
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cells were washed twice in MEM and suspended in a base medium (Ham's F-12) that was 
supplemented with the following hormones and growth factors (F12-7Xm): insulin (5 
pg/ml), cholera toxin (1 rig/ml), transferrin (7.5 pg/ml), hydrocortisone (10
-6
 M), 
triiodothyronine (T3, 3 x 10
-8
 M), endothelial cell growth substance (7.5 pg/ml), and 
retinoic acid (5 x 10
-8
 M). For those cells that were frozen before being used, they need to 
be thawed in 37
 o
C and then go through the same procedure above. 
 Human epithelial cells are considered to be precious since it’s hard to get. Instead of 
being passaged to the snap-wells directly, freshly resected or previously frozen epithelial 
cells were firstly plated onto 100mm collagen coated (10mg Collagen type IV (Sigma C-
7521 or Fisher # OB 1290-01S, .5mg/ml, 20 ml distilled water, 40ul concentrated Acetic 
Acid) plastic plates. The cells were washed every other day with phosphate-buffered 
saline (PBS) solution and then fed with BEGM. The total number of the cells increased 
through growing and dividing until cells became confluent (meaning they are densely 
distributed over the plate). By then enough number of cells were cultured for passaging to 
the snap-wells (0.25-0.3 millions cells/snap-well). This process might take a couple days 
to one week, and it makes sure that relatively small amount of cell cultures can be utilized 
for more experiments. 
 
Passaging cells to snap-wells 
After the cells reached confluence, the media was replaced with Trypsin solution 
containing 1mM EDTA and 0.1% trypsin (Sigma Chemical, St. Louis, MO) to detach the 
cells from the collagen coat. After incubation at 37
 o
C for 10 minutes, most cells were 
detached and were treated with an equal volume of Soybean Trypsin Inhibitor 1 mg/mL 
in F12 (STI) to neutralize Trypsin. The tube with the cell suspension was put into the 
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centrifuge at 1500RPM for 5 minutes. Then the supernatant was aspirated and re-
suspended in the tube in a known volume of media (ALI for bronchial epithelial cells).  
A 
 
B 
 
 
Figure 21: Polycarbonate snapwells for cell culturing. Epithelial cell cultures are grown on a 
polycarbonate plate and clipped to the suspending well (A). The snapwells are then inserted 
into the 6-well tissue culture plate (B). 
         
 
Cells were counted using Trypan Blue dye to determine viability before they were 
passaged onto substrata affixed to polycarbonate cups housed in six-well containers 
(Costar, Cambridge, MA) containing media in both basal and apical compartments. For 
the microelectrode studies, the substratum was a polymerized collagen sheet; for optical 
studies, it was a Falcon Cyclopore membrane (Becton Dickinson, Lincoln Park, NJ). The 
ideal amount of cells is approximately 0.25 million per snap-well. The media ALI is fed 
to both apical and basal compartments on the second day and then every other day until 
the cells reach confluence. After that, only the basal compartment needs media. Once a 
week cells were washed with phosphate-buffered saline (PBS) solution, which was 
aspirated after a few minutes. The cells were monitored daily by measurement of the 
transepithelial potential difference (Vt,) using calomel electrodes interfaced to an 
electrometer (WPI  EVO-M, Sarasota, FL). Cell preparations were routinely studied 
within 1-2 days of the development of the maximal Vt (21 ~28 days from passaging). 
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 Depending on the time when epithelial cells are passaged, they are name as P0, 
the primary cells that are grown on the snapwells right after dissecting from specimen, 
P1, the primary cells after one passage to the 10mm plate and then to the snapwells, and 
P2, cells passaged twice in 10mm plate before growing in the snapwells. For bronchial 
epithelial cells from human lungs, they can be at most passaged twice before moving to 
the snapwells. Some research shows that the surface metabolism of ATP on cultured 
human airway epithelia decays through passage, and is reduced by more than 50% in 
passage 2 cells (Picher, M., pers. comm.) Therefore we also conducted a contrast study 
for different cell passage type in the experiments.  
 
 
4.2.2 SOLUTIONS AND DRUGS 
 
 
For the study of chloride currents, the epithelia were mounted in Ussing Chambers 
with Krebs-bicarbonate Ringer (KBR; in mM, 140 Na
+
, 120 Cl
-
, 5.2 K
+
, 25 HCO
-
, 2.4 
HPO4
2-
, 0.4 H2P04
-
, 1.1 Ca
2+
, 1.2 Mg
2+
, and 5.2 gram glucose) on both theapical and 
basolateral sides. KBR solution resembles the fluid enviroment of the airway surface 
liquid and blood on top and underneath bronchial epithelial cells in human lungs. The CF 
lungs also have this property. Amiloride (Sigma) was present in the apical bath of all the 
experiments at 10
-4
 M to inhibit sodium absorption before addition of ATP, as it’s an 
inhibitor of sodium channel ENaC (there is little sodium current through the basolateral 
membrane). Different concentrations of ATP were dissolved in KBR at 10
-2
 or 10
-1
M and 
diluted into the appropriate bath. After this procedure, all the measured trans-epithelial 
current comes from chloride transport through CaCC, because 1) CFTR is mutated in the 
CF epithelial cells; 2) there are no potassium channel present in the apical membrane; 3) 
the apical and basal bath have the same composition so there will be no contribution of 
transepithelial current coming from shunt compartment. 
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 Chloride-free KBR was used in the study of sodium currents in order to distinguish  
from chloride currents. The only difference of this solution is the replacement of chloride 
ions with gluconate. To get rid of the influence of the chloride out flux from intracellular 
compartment, the epithelia needed to be mounted for at least 30 to 40 minutes before 
adding ATP.  
 Although potassium channels are rare in the apical membrane, postassium currents 
were observed in some epithelia after adding ATP [102]. Chloride-free KBR was then 
modified to include 5mM Ba
2+
 to inhibit potassium channel. Since Ba
2+
 reacts with SO4
2-
 
in the original solution and precipitates, the latter was replaced with Gluconate. (Protocols 
of making KBR, Chloride-free KBR and Chloride-free KBR with 5mM Ba
2+
 are shown in 
the appendix III) 
 
 
4.2.3 USSING CHAMBERS 
 
 Polycarbonate Ussing chambers were milled to fit the plastic cups that supported the 
permeable collagen matrix on which the cells were grown, as described previously. The 
luminal and basolateral sides of the cultures were continually perfused with solutions that 
were warmed (37 
o
C) and gassed (95% O2-5% CO2). Primary cultures were mounted 
vertically in modified Ussing chambers for the measurement (VCC 600 voltage clamp; 
Physiological Instruments, San Diego, CA) of transepithelial potential difference (Vt,). 
The electrical potential of the basolateral side of the tissue with respect to the apical side 
was defined as positive.  
 The transepithelial PD (Vt) was measured by calomel electrodes connected to the 
half-chambers via 3M KC1 agar bridges. The luminal bridge served as the common 
ground for the macro- and microelectrode systems. A second pair of 3 M KC1 agar 
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A 
 
 
B 
 
C 
 
 
Figure 22: Profusion Ussing chamber setup 
for measurement of transepithelial membrane 
short current. A is one set of profusion 
Ussing chambers. The polycarbonate 
snapwell that grows cell cultures (Figure 21) 
is inserted between the two chambers. B 
shows the chambers during the experiments, 
with both chambers filled with buffer 
solution and electrodes in both sides to detect 
the changes in the transmembrane short 
circuit current and membrane potential 
difference. C is the setup with multiple pairs 
of Ussing chambers and the data acquiring 
system that is connected to the computer. 
 
       
bridges connected a pair of Ag-AgCl electrodes to the bath, which permitted passage of 
0.5-s current pulses (I, ~40 microAmp.cm
-2
) every 6 s with a duration of 0.5 s via a 
stimulator [World Precision Instruments (WPI), 301-T] connected to a stimulus-isolation 
unit (WPI, 305). The transepithelial resistance (Rt,) was calculated from the ohmic 
relationship between the deflection of Vt and the current passed. The equivalent short-
circuit current (Ieq) was obtained from Vt and Rt according to Ohm’s Law and 
continuously recorded (Acquire; Dataq Instruments) and stored on a computer hard drive. 
Because the transepithelial current voltage relationships are linear and time independent 
in the physiologic range of potentials, the Ieq accurately estimates the true short circuit 
current Isc.  
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 All protocols started with the measurement of the basal current Ieq, defined as a 
steady-state (< 5 % change) value for > 5 min, followed by drug additions. Drugs were 
added from concentrated stock solutions to either apical and/or basolateral bathing 
solutions. All compounds were added cumulatively, i.e., drugs were not removed before 
addition of subsequent doses or compounds. 
 
 
4.2.4 MEASUREMENT OF TRANSEPTHELIAL CURRENTS WITH APICAL 
EXOGENOUS ATP 
 
 Since all the epithelial cells we used were from CF specimen with mutated CFTR 
and didn’t perform its normal functions. Therefore what was measured was the chloride 
current through Calcium-Actived Chloride Channel (CaCC). Previously, experiments 
have shown that a certain concentration of ATP will stimulate the CaCC and increase the 
apical chlroide permeability. To study the dose-response relationship between ATP and 
chloride current through CaCC, a single dose of ATP (10
-9
 to 10
-4
M) was added to the 
apical side of solution for each set of chambers. The fashion of desensitization was 
studied by applying cumulative doses of ATP (10
-9
 to 10
-4
M). The reason for the choice 
of the dose range is that 10
-9
M (nanomolar) is the in vivo steady state level of ATP in the 
airway surface of human lungs while 10
-4
M is a pharmacological level. The protocol for 
current measurements with cumulative doses of ATP not only helps us to understand  
current desensitization, but also provide more experimental data for single-dose 
measurements. The collection of the data from each chamber when their first dose of ATP 
is added is actually a single-dose measurement.  
 To measure the sodium current across the epithelial, the cell cultures were initially 
bathed with KBR solution and then switched to chloride-free KBR solution in both apical  
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 Events Chamber 
# 1 
Chamber 
# 2 
Chamber 
#3 
Chamber 
# 4 
Chamber 
# 5 
Chamber 
#6 
Chamber 
#7 ** 
Chamber 
#8 ** 
Amiloride (M)*         
ATP 10-9M 10-8M 10-7M 10-6M 10-5M 10-4M Control Control 
 
Table 7: Experimental scheme for measuring the chloride current with single doses of ATP in the apical 
side of the bronchial epithelium cells from CF lungs. 10-4M of amiloride was added to the apical side of 
epithelium to block sodium channel ENaC. Different doses of ATP were added to each chamber afterward 
to measure the induced transmembrane chloride current. Chamber #7 and #8 were used as control. The 
concentration shown in the table presents the level of the agents (amiloride or ATP) in the paical 
compartment AFTER each dose event, NOT the concentration added. 
 
 
 
Events Chambe
r # 1 
Chambe
r # 2 
Chambe
r #3 
Chambe
r # 4 
Chambe
r # 5 
Chambe
r #6 
Chambe
r #7 ** 
Chambe
r #8 ** 
Amiloride (M)*         
ATP (10-9 M)*       Control Control 
ATP (10-8 M) *       Control Control 
ATP (10-7 M) *       Control Control 
ATP (10-6 M) *       Control Control 
ATP (10-5 M) *       Control Control 
ATP (10-4 M) *       Control Control 
 
Table 8: Experimental scheme for measuring the chloride current with cumulative doses of ATP in the 
apical side of the bronchial epithelium cells from CF lungs. 10-4M of amiloride was added to the apical side 
of epithelium to block sodium channel ENaC. Increased doses of ATP were added to a single chamber 
afterward to measure the induced transmembrane chloride current and desensitization. Different chamber 
starts with different initial dose of ATP. Chamber #7 and #8 were used as control. The concentration shown 
in the table presents the level of the agents (amiloride or ATP) in the paical compartment AFTER each dose 
event, NOT the concentration added. 
  
 
and basolateral compartments to eliminate the chloride current from measurement. 
However, at least 40 minutes was needed for the intracellular chloride (~40 mM) to 
diffusion through the cytoplasmic membranes and Ieq to reach steady state. The Ieq 
measurements performed afterward were less affected by the chloride flux and could be 
considered as solely the sodium currents. 10
-4
M of amiloride was added to the chambers 
after the transmembrane current reached a new equilibrium to check if what we measured 
is mainly the sodium current. 
 Experimental evidence shows that ATP not only up-regulates CaCC but also acts as 
inhibits ENaC. In this way, the enhanced salt (Na
+
 and Cl
-
) level drives water flowing 
from cytoplasm to the apical side. This motivated the study of dose-response relationship 
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between ATP and sodium current through ENaC. Because ENaC reacts slower than 
CaCC (the shape of the peak and the relaxation time) upon ATP addition, two different 
types of experiments were done. Some of the earlier experiments showed that in bronchial 
epithelial cells from certain patients, ATP not only up-regulates ENaC, but also induces 
potassium secretion [103]. In several of sodium current measurements we performed, a 
downward peak was observed after ATP induction (Figure 23), which is thought to be a 
transepithelial outflow of potassium ions from cytoplasm.  
 
A 
 
B 
 
Figure 23: Sodium current measurements induced by cumulative doses of ATP on P2 epithelial cells from 
CF patients (A and B were from different patients). The downward peaks induced by ATP are thought to 
relate to potassium secretion.  
 
 
 The experiment schemes (Table 9 and 10) studies how single- and cumulative- dose 
of ATP with different concentrations affect the sodium currents. 
 
Events 
Chamber 
# 1 
Chamber 
# 2 
Chamber 
#3 
Chamber 
# 4 
Chamber 
# 5 
Chamber 
#6 
Chamber 
#7  
Chamber 
#8  
ATP (M)* 10-9  10-8  10-7  10-6  10-5  10-4  10-3  Control 
Amiloride (M)* 10-4 10-4 10-4 10-4 10-4 10-4 10-4 10-4 
 
Table 9: Experimental scheme for measuring the sodium current with single dose of ATP in the apical side 
of the bronchial epithelium cells from CF lungs. The epithelial cells from CF patients were bathed in the Cl-
free KBR solution until the transmembrane current reached equilibrium. Different doses of ATP were then 
added to each chamber to measure the change in transmembrane sodium current. 10-4M of amiloride was 
added to the apical epithelium to check if the measured current was mainly through sodium channels. 
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Events 
Chamber 
# 1 
Chamber 
# 2 
Chamber 
#3 
Chamber 
# 4 
Chamber 
# 5 
Chamber 
#6 
Chamber 
#7 ** 
Chamber 
#8 ** 
ATP (10-9 M)*       Control Control 
ATP (10-8 M) *       Control Control 
ATP (10-7 M) *       Control Control 
ATP (10-6 M) *       Control Control 
ATP (10-5 M) *       Control Control 
ATP (10-4 M) *       Control Control 
Amiloride (M)*         
 
Table 10: Experimental scheme for measuring the sodium current with cumulative doses of ATP in the 
apical side of the bronchial epithelium cells from CF lungs. Increased doses of ATP were added to a single 
chamber to measure the induced transmembrane chloride current and desensitization. 10-4M of amiloride 
was added to the apical epithelium to check if the measured current was mainly through sodium channels. 
  
 
 To simulate a situation that is similar to what happens in vivo, a third type of 
experiments was designed to measure the sodium current through ENaC and chloride 
current through CaCC together. In this case, epithelial cells will be mounted bilaterally in 
KBR solution and 10
-4
M amiloride will be added in apical side following the dose of 
ATP. We only conducted single-dose experiments on this system. 
 
Events 
Chamber 
# 1 
Chamber 
# 2 
Chamber 
#3 
Chamber 
# 4 
Chamber 
# 5 
Chamber 
#6 
Chamber 
#7  
Chamber 
#8  
ATP (M)* 10-9  10-8  10-7  10-6  10-5  10-4  10-3  Control 
Amiloride (M)* 10-4 10-4 10-4 10-4 10-4 10-4 10-4 10-4 
 
Table 11: Experimental scheme for measuring the transmembrane current that is composed of both sodium 
and chloride ions. The epithelial cells from CF patients were bathed in the regular KBR solution. Different 
doses of ATP were then added to each chamber to measure the change in transmembrane sodium current. 
10-4M of amiloride was added to the apical epithelium afterward to check the ratio of chloride current and 
sodium current. 
 
 
 
 
 
 
4.3  EXPERIMENTAL RESULTS WITH ATP 
 
 
4.3.1 MEASUREMENT OF CHLORIDE CURRENT 
 
 
To get a basic idea about the response of CaCC to ATP using both a single dose and 
cumulative doses, we initially conducted cumulative doses experiment multiple times, 
 71 
 
 
because this method not only provides ingle-dose data but also information on 
desensitization. We measured the chloride current with cumulative stimulation of ATP 
ranging from 10
-9
M to 10
-4
M several times on P1 cells (for details see 4.2.1). As shown in 
Figure 23, it seems that the chloride channel CaCC starts to be effectively activated by 
ATP when its concentration is higher than 10
-6
M (micro-Molar). This observation helps 
us to adjust our protocols for chloride current measurements to exclude the ATP doses 
under 10
-6
M at later times. Doses higher than 10
-4
M are beyond the pharmacological 
range and will be less useful for our study. So in the end the ATP doses we induced in the 
experiments are 10
-6
, 10
-5
 and 10
-4
M. 
  In general, the chloride current follows a quick drop in response to apical amiloride 
and remains at the lower level for the entire course of the experiment, which shows that 
amiloride binds to sodium channel in a very fast and tight way. The typical response to a 
sinlge dose of ATP is a sharp peak (quick increase and decrease) within the first a few 
minutes. The peak later becomes wider and returns to a level that is very close to the one 
before adding ATP in 10~30 minutes, depending on the concentration of the dose. As the 
level of ATP increases, so does the relative height of the peak.  
 The experiments with cumulative doses indicate different rates of desensitization in 
P1 and P2 cells. Most of P1 cells and some of P2 cells have increase in peak on the 
second dose (10
-5
M) and a huge reduction of the peak after the third one (10
-4
M). The rest 
of P2 cells show a consistent reduction in peak after the increasing doses. We also found 
that the absolute values of response in most P2 cells are bigger than those from P1’s. 
These two lines of evidences indicate that CaCC in P2 cells are more sensitive to ATP 
than P1’s, so that it not only has a bigger response to each dose, but also becomes 
desensitized at a lower dose (10
-5
M).  
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Figure 24: Chloride current measurement with cumulative doses of ATP ranging from 10-9M to 10-
4M. All of these three experiments were conducted using P1 CF epithelial cells. 
 
 
 
 
 
 
 
 
Figure 25: Chloride current measurement with single dose of ATP ranging from 10-6M to 10-4M. 
A used P1 cells while B and C are from P2 cells. 
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 Besides the qualitative analysis of CaCC response to apical ATP (the shape of 
reponse, and time span), we also studied quantitatively the different aspects of the 
response. Two key questions we addressed in both types of experiments are: 1) whether 
the chloride current returns to its basal level following the addition of ATP; 2) what is the 
correlation between the response and the concentration of ATP. The first one addresses 
the concern that the signal initiated by ATP permanently changes the permeability of 
CaCC. The second question is obviously more important for studying the dose response 
relationship, which serves as a tie for integrating the biochemical network model (Chapter 
2) with the ion/water flux model (Chapter 3). With this motivation, we first calculated the 
relative change of steady state level of the current before and after ATP addition (the first 
group of bars in Figure 27A and B) and the relative height of the peak induced by ATP 
(the second group of bars in Figure 27A and B) based on the data from experiments with 
single dose of ATP. The relative baseline was obtained from 
                    
 
I
new,ss
 I
old ,ss  Iold ,ss 100%  (4.1) 
 
where ―ss‖ stands for steady state. Similarly, the relative height of peaks was calculated 
as 
                      
                   
 
I
peak
 I
old ,ss  Iold ,ss 100%  (4.2)              
 
 
As the data in Figure 27 show, the chloride current, on average, comes back to the 
previous baseline level after being induced by ATP within 30 minutes. And as the level of 
ATP increases, so does the relative height of the peaks. Although Figure 27A shows a 
rather small 
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Figure 26: Chloride current measurement with cumulative doses of ATP ranging from 10-6M to 
10-4M. A, B and C were obtained from P1 cells while D, E, F, G are from P2 cells. Notice all the 
figures are cut off from the moment after the apical side in induced with 10-4M amiloride. 
  
difference between dose 10
-6
, 10
-5
 and 10
-4
M in P1 cells, data from P2 cells (Figure 27B) 
indicate a very significant difference in the response to different doses. Although the 
sample size is still relatively small, this observation gives some hints that as cell passage 
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type varies, the dose response curve varies too. For example, in P1 cells, the dose 
response might have a jump at 10
-4
M while in P2 cells. There is probably a steady 
increase right from 10
-5
M all the way to 10
-4
M. 
 
 
 
 
 
Figure 27: Quantitative analysis of the data from chloride current measurement with single dose 
ATP. A shows analysis from the experiments on P1 cells. B was on P2 cells. The first three bars 
from left in each subfigure represent the relative change of baseline before and after adding ATP 
with various concentrations. The three bars from right are relative height of peaks induced by 
ATP with various concentrations. 
 
We also applied the same data analysis to experiments with cumulative doses of 
ATP. Two scenarios were studied: the experiments with three cumulative doses 
(consequently 10
-6
M, 10
-5
M, and 10
-4
M), and ones with only two (consequently 10
-
5
M, and 10
-4
M). When studied in an averaged fashion, data from the three-dose 
experiments show a very similar trend in the relative height of peaks on both P1 and 
P2 cells. That is, the chloride channel CaCC is desensitized gradually and has a big 
collapse after 10
-5
M. Comparison of Figure 28C and D indicates again P2 cells are 
more sensitive to a given concentration of ATP in a certain range (>10
-7
M, other wise 
no response whatsoever) than P1 cells, although the channels are desensitized back to 
the same level after 10
-5
M. 
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Figure 28: Quantitative analysis of the data from chloride current measurement with 
cumulative doses of ATP. A and B are analysis from the experiments with three 
cumulative doses of ATP (consequently 10-6M, 10-5M, and 10-4M) on P1 and P2 cells, 
respectively. C and D are analysis from the experiments with two cumulative doses of 
ATP (consequently 10-5M, and 10-4M) on P1 and P2 cells, respectively. 
   
 
   
 
4.3.2 MEASUREMENT OF SODIUM CURRENT 
 
To briefly learn the response of sodium channel regulation by ATP, we conducted 
a cumulative dose-response experiment on P1 cells (Figure 29).  
 
Figure 29: cumulative dose response 
experiment on sodium current with ATP 
ranging from 10-9M to 10-4M on CF epithelial 
P1 cells. 
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We observed a similar dose response range to ATP as in chloride current case. That 
is, doses lower than 10
-6
M have little effect on the sodium current via ENaC channel. So 
we modified the experimental plan (4.2.4) of single dose- and cumulative dose-response 
experiments to use ATP with a smaller range from 10
-6
M to 10
-4
M. As shown in Figure 
29, the response of ENaC to ATP is different from that of CaCC in the following aspects 
(Figure 24): 1) The peak induced by the same dose of ATP within the first minute or two 
is much shorter. 2) On average the current reaches its minimum with in approximately 15 
minutes after the dose of ATP. The minimum is always below the baseline. 3) After 
reaching a minimum value, the current either stays there or recovers back to a lower 
baseline. Although we don’t have enough data from P1 cells for this type of experiments, 
the amplitude of peaks from data on P1 cells (Figure 30A) and P2 cells (Figure 30B, C, 
D, E) indicates that ENaC in P2’s are possibly more sensitive to ATP. The drop of the 
current induced by 10
-4
M amiloride, in comparison with the change in chloride current 
experiments, is quite small. That shows that ATP doses from 10
-6
 to 10
-4
 are able to turn 
off most of ENaC’s in apical membrane. The quantitative analysis on data in Figure 31 
and collected data from cumulative dose-response experiments in Figure 4.14 shows a 
similar inhibition effect in the relative change of baseline (three bars from left in Figure 
31) for the three doses. Similar to the chloride current experiments, the peaks induced by 
ATP for different doses (middles group in Figure 31) increases as the dose increases. 
Although the recover is very significant from Figure 30F and Figure 32A, the quantitative 
analysis (three bars from right in Figure 31) indicates a very small recovery on average, 
the definition of which is as follows:  
 
                                     
 
I
new,ss
 I
min  Inew,ss 100%     (4.1) 
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Figure 30: Sodium current measurement with apical single dose of ATP on CF epithelial cells. A 
are data from P1 cells and B, C, D, E, and F are on P2 cells from different CF patients. 
 
 
 
 
 
Figure 31: Quantitative analysis of the data 
from sodium current measurement with 
single dose ATP on P2 epithelial cells. The 
first three bars from left represent the 
relative change of baseline before and after 
adding ATP with various concentrations. 
The three bars in the middle are relative 
height of peaks induced by ATP. The three 
from left are the relative relaxation with 
respect to the new baseline. 
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We observe desensitization of ENaC by cumulative doses of ATP in Figure 32. The 
data analysis in Figure 33 also confirms this. Interestingly, the cumulative doses not 
only desensitize the response shown by the peaks (middle group in Fig 33A and B), 
but also the change of baseline (bars from left in Figure 33A and B). Because there is 
only one experiment done on P1 cells, we only could conclude that the recovery for 
P2 cells in this type of experiments is hardly noticeable.  
  
  
Figure 32: Sodium current measurements by cumulative doses of ATP on apical side of CF 
epithelial cells. A is from P1 cells and B, C, D are data from P2 cells. 
  
 
 
 
 
 
Figure 33: Quantitative analysis of the data from sodium current measurement with cumulative 
doses of ATP. A is the analysis from the experiments with three cumulative doses of ATP 
(consequently 10-6M, 10-5M, and 10-4M) on P2 cells. Data from B are from two cumulative doses 
of ATP (consequently 10
-5
M, and 10
-4
M) on P2 cells. 
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4.3.3 MEASUREMENT OF MIXED CURRENTS  
 
 
Our experience from previous experiments, which studied sodium channel (ENaC) 
and chloride channel (CaCC) individually, helps us to narrow the dose of ATP to 10
-6
 to 
10
-4
M for the mixed currents. We observed combined characteristics from both ENaC and 
CaCC responses induced by ATP in Figure 34. The chloride current obviously plays an 
important role in the response induced immediately following the addition of ATP, 
because the peak is much higher than those of ENaC response. However, regulation of the 
sodium channel has a much longer effect on the total measurements. That’s why we see 
the minimum point that is much lower than the baseline (Figure 34B and C) and 
sometimes a recovery at higher doses like 10
-4
M and 10
-5
M (Figure 34A).  
 
  
 
 
Figure 34: Single dose response of mixed current (INa+ICl) induced by ATP (10
-6, 10-5 and 10-4M) 
on P2 human epithelial cells. A, B, C are on P2 cells from different CF patients. 
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4.3.4 FACTORS THAT AFFECT THE MEASUREMENTS  
 
Our previous observations made us wonder about the several different factors in 
these experiments that might affect the outcome. First of all, we wanted to learn whether 
the chloride-free KBR buffer with 5mM barium does anything other than inhibiting 
potassium secretion and secondly how the cell passage type affects measurements of 
sodium and chloride currents. Notice the baseline current for both INa and ICl are relatively 
low (5~10 A/cm2), which makes the study of dose response relationships, especially the 
sodium current recovery, very hard. The low baseline makes the recovery, if there is any, 
seem very small. Because dexamethasone, a hormone, has been shown to upregulate 
ENaC
 
mRNA expression [104], we used it as a pretreatment for the cell cultures. The 
pretreatment with Dexamethasone in the media starts after two weeks of cell culturing 
and lasts normally 3 days. Pretreatment with a longer period is also tested in our 
experiments. 
To test how the buffer and cell passage type make a difference in the measurements, 
we got P0, P1 and P2 cells from the same cell line and conducted sodium and chloride 
current measurements on each of them. In each sodium current experiment, we also tried 
to run the cells with same ATP dose in different buffers, one in bilateral Cl-free KBR 
with 5mM barium and one without barium. 
With the pretreatment of Dexamethasone, a 5 to 8 fold of increase in the current 
baseline was observed in sodium current measurements (Figure 35). However the 
increase in baseline was not found in the chloride currents. This confirms that 
Dexamethosone is able to selectively up-regulate apical ENaC. Meanwhile, a recovery in 
sodium current measurement is observed (Figure 35). The higher the dose is, the more 
obvious the recovery. Comparison of the two curves in each subfigure of Figure 35 shows 
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no significant difference that 5mM barium makes in the buffer. And if we compare the 
columns, which represent the same dose of ATP but in different cell types, cell passage 
type didn’t affect the outcome very much. We observed a slightly different behavior for 
chloride currents (Figure 36). As we would expect, Dexamethasone didn’t over express 
CaCC response to ATP. The baseline current is really low (<5A/cm2). Meanwhile it 
seems that P2 cells are at a higher baseline than P1’s and P0’s. The response of CaCC to 
ATP in P2 cells is higher than the other two types as well.  
 
   
   
   
Figure 35: Sodium current measurements induced by various doses of ATP on P0 (A, B, C), P1 (D, E, 
F) and P2 (G, H, I) human epithelial cells. In each figure, the measurements in lighter color were done 
in bilateral chloride-free KBR solution. Those in darker color were done in bilateral chloride-free KBR 
solution with 5mM barium in apical side. 
 
Notice these results are based on cells from a single cell line. To make the 
conclusion whether cell type really makes a difference in sodium current measurements, 
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experiments need to be done on different cell lines. The observation that P2 cells are more 
sensitive in both chloride and sodium current measurements may still hold. 
        
 
  
   
   
Figure 36: Chloride Sodium current measurements induced by various doses of ATP on P0 (A, B, C), P1 
(D, E, F) and P2 (G, H, I) human epithelial cells. The two curves in each sub-figure are repeated 
measurement in two different chambers with the same type of cells (pre-treatment and cell line) and 
same buffer. 
 
 
 
4.4    EXPERIMENTAL RESULTS WITH UTP  
 
UTP have similar effects on airway surface liquid regulation by activating the apical 
membrane receptors and regulating the transmembrane ionic flows. We replaced ATP 
with UTP and UDP and followed the same experimental protocol as before to study their 
regulation characteristics. We’ve tried these two drugs on two types of cell cultures, the 
bronchial human epithelial (HBE) cells and a type of cancer cells H441 [101]. H441 cell 
has similar bioelectric properties of HBE cells except it lacks of chloride channels in the 
apical membrane. Therefore it could be used to measure the sodium response to the two 
drugs without having to using Cl-free KBR solution. We also did some control test by  
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Figure 37: Chloride current and mixed current measurements induced by various doses of UTP on 
P2 HBE cells. Figure 4.18A shows the change of the chloride current induced by UTP. Cells with 
and without treatment of dexamethasone are compared in the same figure (A) with a zoomed figure 
(B) showing the scale of the response. C and D are the changed of the mixed current induced by 
UTP, provided by the HBE cell cultures from two patients).  
 
A 
 
B 
 
C 
 
 
Figure 38: Sodium current measurements 
induced by various doses of UTP on H441 
cells. A and B are the change of the sodium 
current induced by single-dose of UTP. C is the 
changed of the sodium current by cumulative-
dose of UTP. 
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treating both types of cells with Dexamethasone  and compare the measurements with 
those without the treatment. 
In comparison with the regulation of ATP on ENaC in HBE cells from CF lungs, UTP 
induced the sodium channel regulation in H441 cells are somehow different. First, the 
peak of the response is much smaller (Figure 38A and B). Meanwhile, the relaxation time 
of the current, i.e., the time to reach a new steady state is about 20 ~30 minutes. 
Compared to the time of ATP response (~60 minutes), it is much shorter.  The 
measurements from the cumulative –dose experiments showed a desensitization of 
signaling pathway to UTP (Figure 38C).  
The response of the chloride channel CaCC and the response of both CaCC and ENaC 
channels to single dose of UTP (Figure 37) has similar curvature as that of ATP in the 
HBE cells. Dexamethasone seems to significantly increase the baseline current, as seen 
before. Because we currently have measurements from cell cultures of one patient, it is 
hard to study the amplitude of the response.  
 
4.5   MODELING THE RESPONSE  
 
We’ve studied the individual response of ENaC and CaCC channels to various doses 
of apical ATP through electrophysiological experiments. Differences in the dynamics of 
the responses, such as the time scale, the response amplitude, and the relaxation behavior, 
were identified. The average level of the induced change in the short-circuit current 
through CaCC, i.e. the height of the peak in the current relative to the baseline, is 
proportional to the dose of ATP. This is also true for the ENaC response. Meanwhile, we 
also saw a decreasing trend in the minimum value of INa as we increase ATP level. This 
study is essential for CF because it not only provides a fundamental evidence for the 
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response of HBE cells to ATP, but also insights into the design of novel therapeutic drugs 
given the different response of the two channels. As a matter of fact, aerosol nucleotide 
delivery and the use of amiloride in the airway surface of CF lungs, separately or in 
combination, have become two typical ways to treat CF. The former affects current 
through CaCC while the latter ENaC. Due to the difficulty in getting specimens of human 
bronchial epithelial (HBE) cells from CF patients and the time involved in culturing them, 
we are not able to collect enough samples to decrease the error bars in these figures. 
Therefore the study remains qualitative.  
  As mentioned earlier, the ion water transport model proposed by Novotny et al. 
added volume regulation to the permeability of the apical membrane Cl
-
channel and to 
the maximum flux of the basolateral membrane cotransporter. As the mechanism for the 
channels and transporters to detect apical and cell volumes remains unclear in this 
model, a linear coupling was assumed for the volume with prescribed upper and lower 
bounds on the permeability and maximum flux. In our integrated model, we are going to 
assume a more realistic nonlinear coupling that does not require the specification of 
artificial upper and lower bounds. We want to begin by simulating the airway epithelium 
in normal lungs. Experimental observations suggest that the two apical ion 
permeabilities and the airway nucleotide and nucleoside concentrations normally follow 
the dose-response type of relationship. These curves can be mathematically modeled by 
writting the permeability of apical membrane to chloride and sodium ions, i.e. PCl,a and 
PNa, as nonlinear sigmoid functions of these two metabolites as shown in Eq.(4.2)  and 
Eq.(4.3). The extra term aNa,0 and the minus sign in front of nonlinear term in Eq.(4.3) 
indicate the opposite effect of nucleotide and nucleoside have on the ENaC channel 
compared to that on CaCC.                      
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PCl,a CATP (t),CADO (t) 
aCl,1
aCl,2  aCl,3e
CATP ,SSCATP (t )

aCl,4
aCl,5  aCl,6e
CADO,SSCADO (t )   (4.2)                   
PNa,a CATP (t),CADO (t)  aNa,0 
aNa,1
aNa,2  aNa,3e
CATP ,SSCATP (t )

aNa,4
aNa,5  aNa,6e
CADO ,SSCADO (t )
  (4.3) 
 
 
These two equations serve as a connection for integrating the ATP regulation model 
and ion/water transport models. For the resting state, the level of nucleotides and 
nucleosides in the airway is not enough to activate the signaling pathway. However, when 
a big amount of ATP or adenosine is added to the airway, it starts the signaling process 
and changes the permeabilties of the two apical channels and leads to the change of the 
ions and water flows. Later this process will be terminated by the decrease in the 
concentrations of ATP and adenosine, caused by the catalysis of the enzymes on the 
membrane surface and dilution from water influx to the airway.  
The baseline conditions for membrane permeability to chloride and sodium ions are 
different in normal and CF lungs and leads to different dose response relationship, and 
therefore different choices of parameter values in Eq.(4.2)  and Eq.(4.3) in these two 
types of tissue culture. Based on the setup of the integrated model, we came up with 
different ways to test it systematically as shown in Table 12. Basically the different 
scenarios have been labeled with various signal numbers. When a certain scenario is 
chosen, say adding 100 M ATP to the airway epithelium of a CF lung, the integrated 
system will automatically input 100 M to ATP regulation model as initial condition, 
choose permeability values that belongs to CF lungs for the ion/water transport model, 
and select the right dose-response relationship for CF epithelium to ATP and adenosine. 
Although we currently do not have enough information to find out the dose 
response relationship in Eq(4.2)  and Eq (4.3), we built a ―toy‖ model, which  combines 
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the ATP regulation model and ion/water transport model. Two ―pseudo” dose response 
functions were also used to connect the two models in the whole system. The amounts of 
ATP and adeonsine in the ASL were set to be the same as in vivo conditions. We then 
changed the permeabilities from normal lungs to CF lungs [105] and tested the model 
under the conditions of aerosol ATP and hypertonic saline solution treatments. In 
agreement with the in vivo condition of CF epithelium which has an over-expressed 
apical sodium channel and no CFTR Cl channel, the apical membrane permeability to 
sodium ion, PNa,a, was set to be 6.2 10
-8
 m/s and Its permeability to chloride, PCl,a was 
decreased to 0. When these changes were made to the parameter set in the model, we ran 
it from steady state and tried to study the outcome of the model. For the condition that no 
treatment is conducted to the CF airways, we observed a much lower resting level for 
ASL (4 m). And in both simulations for aerosol ATP treatment (Fig39B) and hypertonic 
challenge (Fig39C), the ASL increases due to the regulated CFTR and ENaC and settles 
at levels that are much higher than 7 m. All these simulation results agree with 
experimental observation under these conditions, which suggests that our integrated 
model is able to capture the key features of ASL regulation and provide its potential for 
the drug study to treat CF.  
 
Lung Type Features Scenarios 
Ion 
channels 
Initial Ion 
composition 
CF Lung 
CFTR doesn’t function.  
 
P2Y2-R-activated 
pathway regulations 
through apical CaCC and 
ENaC 
 
Aerosol ATP 
CFTR: off 
CaCC: on 
ENaC: on 
Steady state 
Hypertonic 
saline 
CFTR: off 
CaCC: off 
ENaC: on 
Increased 
Amiloride 
CFTR: off 
CaCC: off 
ENaC: off 
Steady state 
 
Table 12:  Different scenarios for testing the integrated model in CF lungs.  
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A 
 
B 
 
C 
 
Figure 39: Testing the integrated model 
under different treatment conditions for CF 
airways. The apical volume without any 
regulation (A) goes to 3m. The airway 
after apical addition of 100 M ATP (B) or 
hypertonic solution (C), in which [NaCl] is 
10 folds higher than normal) , is 
replenished and settles at higher volume . 
 
4.6   CONCLUSION 
 
ASL regulation is a very complicated system. There are still unsolved questions in 
understanding how it works in CF and normal lungs. To study this system, we 
compartmentally divided it into two components, the ATP regulation in the airway and 
the ion/water flux across the epithelial membrane. We then built each component based 
on the current information we collected from literature and in vivo and in vitro 
experiments at CF center at UNC. Due to the lack of information on the dose response 
relationship between ATP/UTP and ion current or ion permeabilities, it is hard to use real 
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experimental data to test the integrated model that combines the ATP regulation and the 
ion/water flux modules. However, the in vitro experimental results shown in this chapter 
have provided useful information on dose response relationship.  The key characteristics 
of dose response from early stage experimental observations, i.e., both the dynamics and 
relaxation time scale of the ionic current, made it possible for choosing mathematical 
functions to model the curvature of dose response relationship. Although the detailed 
information on the coefficients in these functions is yet to be decided as of now, we 
temporarily chose coefficients that could keep the dose response curves in a biologically 
reasonable range and integrate the two models in the previous chapters.  
The model was not only able to simulate the lower height of ASL when no 
regulation of drug was involved (Fig39A). More importantly, it also showed a positive 
regulation on the ASL with ATP treatment (Fig39B) and hypertonic challenge (Fig39C). 
It is the first model that includes so many characteristics of ASL. Now that we have tested 
it under the three most important conditions and have observed the agreement with 
experimental data, we are very confident that this model could contribute tremendously to 
understanding CF and to the drug study of CF. After enough information is collected to 
accurately define the dose response between the drug and ionic currents, we could have a 
even finer tuned integrated model. In the future, we could also study the spacious drug 
effect by adding diffusion into this model and even include the hydrodynamics of ASL to 
simulate more realistic conditions of the lungs. 
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Appendix I: 
OPERATOR-SPLITTING METHOD 
Operator-Splitting method is a common way to numerically solve 
reaction/convection diffusion equations, where reaction/convective and diffusive forces 
are accounted for in separate substeps. The operator splitting method, also called time 
splitting or the method of fractional steps is widely used in solving initial value partial 
differential equations, which involves more than one operator on the right-hand side of 
the equation. 
Suppose we have an initial valued equation of the form  
                                          
 
u
t
 Lu   (4) 
 
Where L is some operator. While L is not necessarily linear, suppose that it can at least be 
written as a linear sum of pieces, which acts additively on, 
                         Lu = L1u + L2u + L    Lmu  (5)
  
In the reaction diffusion equations, we normally have two operators, the reaction 
term and the diffusion term. So we will start with case m = 2, i.e. L = L1 + L2. By writing 
the operators in the form of, our equation looks like a standard growth equation 
                                            
 
X
t
 AX   (6) 
with solution  X (t)  X (0) exp(tA) . Although we do not have a simple multiplier, the 
same principle applies. Namely, our exact solution is  u(t)  u(0) exp(tL) . By Taylor 
expansion, exp(tL) can be written as follows 
 
 
exp(tL)  1 tL 
t2
2!
L2 
t3
3!
L3 L  (7) 
Therefore the change over 1 time step is 
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u(t  t)  exp t  t L u(0)
               =exp tL exp tL u(0)
               =exp tL u(t)
 (8) 
Suppose that for L, we already know a difference operator scheme for updating the 
variable from time step n to time step n + 1, which can be written symbolically as 
                                  
 
u
n1  F t un   (9) 
Comparing  and ,  F t  can be thought as a numerical approximation of  exp tL . In 
the case of two operators, we could write the scheme as follows with only the first two 
terms in the Taylor expansion of each operator. 
                                
 
u*  I  tL
1 u
n   (10) 
                                
 
un  I  tL
2 u
**   (11) 
 F t  in this case is combination of the two with overall first error accuracy. 
                 
 
F t  I  tL2  I  tL1 
           = I  tL
1
 tL
2
 t2L
2
L
1
           = I  tL  t2L
2
L
1
           = exp(tL) O t2 
 (12) 
Notice that the order we put the two sets of terms from Taylor expansion should follow 
the sequence we apply the operator on. 
Suppose we have second-order schemes for L1 and L2. 
             
 
F
1
t  I  tL1 
t2
2!
L
1
2 O t3  (13) 
            
 
F
2
t  I  tL2 
t2
2!
L
2
2 O t3  (14) 
 
Sequential application would give 
 
F
2
t F1 t  I  t L1  L2 
t2
2!
L
2
2  2L
2
L
1
 L
1
2 O t3  (15) 
The above seems like a second order scheme. Yet we still need to be careful to make the 
judgment. Since the order of applying the operators is important, if we compare  with , 
the Taylor expansion of the exact operator L = L1 + L2, we can see some difference. 
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exp tL  exp t L1  L2  
               I  t L
1
 L
2 
t2
2!
L
2
2  L
1
L
2
 L
2
L
1
 L
1
2 O t3 
 (16) 
So the scheme is not second order unless L1L2 = L2L1. If this is satisfied, it is said that L1 
and L2 ‖commute‖. 
As we can see from the derivation above, whether the two operators are 
commutable is a prerequisite to achieve the second order accuracy. As this condition may 
not be satisfied by every problem you work on, people were thinking of other schemes so 
that both operator splitting and high accuracy can be achieved. That’s why Strang 
splitting method came up in 1968.  
The basic idea of Strang splitting is like this. Suppose the reaction term L1 and 
diffusion term L2 in the system happen at different time scales. For example, reaction is a 
faster process than diffusion. Then operator term L1 can be further split as L1/2 + L2/2. 
Therefore the difference operator  F t is as follows, 
                         
 
F t  F1 t 2 F2 t F1 t 2                    (17) 
which means that we should take half-step with L1, full step with L2 and then half step 
with L1. To verify this is a second order scheme, we can just multiply the two difference 
operators together assuming and do not commute. 
 
F t  F1 t 2 F2 t F1 t 2 
           = I  t 2 L1  t 2 
2
L
1
2 2!O t3  
              I  tL
2
 t2L
2
2 2!O t3  
              I  t 2 L1  t 2 
2
L
1
2 2!O t3  
           = I  t L
1
 L
2 +t
2 L
1
2  L
1
L
2
 L
2
L
1
 L
2
2  2! +O t3 
 (18) 
 
Comparing  to , we can see that no matter L1 and L2 commute or not, the overall accuracy 
is the second order. 
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Having said all above, we now consider the second order schemes to solve each 
operator in the reaction diffusion equation. The reaction term, along with time derivative 
on the left-hand side, forms an ordinary differential equation. 
                                
 
u
t
 R u(x,t),t   (19) 
In this ODE, u and x are both vectors. u denotes the characters for different species in the 
system, say number of molecules or concentration, while x is the domain where the 
system is in. We can use any of our favorite second-order numerical schemes to solve it, 
for example Runge-Kutta 2. 
                          
 
k
1
 tR u
n
,t
n 
k
2
 tR u
n
 k
1
2,t
n
 t 2 
u
n1
 u
n
 k
2
O t3 
 (20) 
where un = u(xn; tn). 
As for the diffusion term, 
                                
 
u
t


x
D
u
x




  (21) 
 
to put it in a simple way, we make such assumptions : (1) The diffusion process is in one 
dimension along the z axis; (2) All the species in the system diffuse at the same rate; (3) 
The medium along the x and y axes are homogeneous, i.e., the diffusion coefficient for 
the i
th
 species Di is a constant. Then the diffusion equation for the i
th
 species can be 
written as 
                                      
 
u
i
t
 D
i
2u
i
z2
  (22) 
 
In the following, we will drop the subscription i for the purpose of convenience. The 
above forms a parabolic equation and the typical way of solving it is the finite difference 
method shown in (18). However there is another scheme called ‖Crank Nicolson scheme 
‖ which has same accuracy order but is stable no matter what t and z you choose. 
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u
j
n1  u
j
n 
Dt
z2
u
j1
n  2u
j
n  u
j1
n  (23) 
Developed by John Crank and Phyllis Nicolson in the mid 20th century, the Crank-
Nicolson method is a finite difference method used for numerically solving the heat and 
related equations. 
 
u
j
n1  u
j
n  u
j1
n1  2u
j
n1  u
j1
n1  u j1n  2u jn  u j1n    (24) 
 
where 
 
  Dt 2z2 . To say the same thing with equations, move all the n + 1 terms 
in  to the left and the n+1 terms to the right, obtaining 
-  
 
u
j1
n1  (1 2)u
j
n1 u
j1
n1 u
j1
n  (1 2)u
j
n u
j1
n  (25) 
 
Now think of the left side of equation  as containing all the unknown quantities and the 
right side as containing all known quantities. We can rewrite equation as a set of 
simultaneous equations. 
 
  
A
bottom
 0
 1 2  0
0  1 2  0
0 O O O 0
0  1 2 
0  A
top




















u
1
n1
u
2
n1
u
3
n1
M
u
m1
n1
u
m
n1







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


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







B
bottom
u
1
n  1 2 u2
n u
3
n
u
2
n  1 2 u3
n u
4
n
M
u
m2
n  1 2 um1
n u
m
n
B
top






















     (26) 
 
 
where bleft and bright are adjustable and have to do with the boundary conditions on the 
bottom and top of the domain the reaction and diffusion happen.  For ADP and AMP that 
are not released or uptake at epithelial membrane, they have no-flux boundary condition. 
This means in Eq ((26)) 
                                       
 
u
j1
n1  u
j
n1   (27) 
 
                                        
 
u
j1
n  u
j
n   (28) 
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and therefore we have 
 
  
1  0
 1 2  0
0  1 2  0
0 O O O 0
0  1 2 
0  1




















u
1
n1
u
2
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u
3
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


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3
n
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2
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n u
4
n
M
u
m2
n  1 2 um1
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u
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
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


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

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

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






      (29) 
 
For the case of ATP, because it follows a constant release rate from epithelial cells, it has 
its release form shown in the boundary condition at z=0 as follows  
                               
 
J
ATP
  D
u
z
z0
 (30) 
 
                              
 
u
0
 u
1

J
ATP
z
D
  (31) 
 
If we write it in a discrete fashion, this equation becomes Eq.(32), and it holds for all the 
time steps. Again, the boundary condition at he fluid surface still remains to be ‖no-flux‖. 
This way, the matrix operation become 
 
  
1  0
 1 2  0
0  1 2  0
0 O O O 0
0  1 2 
0  1




















u
1
n1
u
2
n1
u
3
n1
M
u
m1
n1
u
m
n1





















(1 )u
1
n u
2
n
u
1
n  1 2 u2
n u
3
n
u
2
n  1 2 u3
n u
4
n
M
u
m2
n  1 2 um1
n u
m
n
u
m1
n  (1 )u
m
n






















      (32) 
 
The matrices for solving concentrations of adeonsine and inosine are a little trickier to 
derive because the uptake of these two nucleosides follows nonlinear Michaelis Menten 
Kinetics shown in Eq.(33). We need to linearize it under a certain conditions in order to 
construct the first row of matrix A.  
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J
uptake
  D
u
z
z0
 
V
max
u
K
M
 u
 (33) 
 
 
u
0

u
1
 K
M
V
max
z D  KM Vmaxz D u1 
2
 4K
M
2
 (34) 
 
The experiment we are simulating starts initially with 100 uM of ATP while zero 
other species in the system. As we could observe from the experimental measurements, 
time dependent concentration of inosine within the first 60 minutes ranges from 0 to less 
than 20 uM while that of adensoine from 0 to 80 uM. Both of them have similar uptake 
rates (Vmax=0.45 uM/min, KM=17uM).  The comparison of KM and adeonsine and inosine 
levels indicates that it it’s not justifiable to linearize the Michaelis Menten term. Instead, 
the two grid points around the boundary should follow a relationship that holds for all 
time steps shown in Eq(??).  However, if we study the dynamics of the system around 
steady state in which adenosine are at very down stream of micromolar scale 
([ADO]ss=0.168uM, [INO]ss was not measured), Eq.(33) could be linearized as  
 
 
J
uptake
  D
u
z
z0
 
V
max
u
K
M
 u
: 
V
max
K
M
u  (35) 
 
and  
                    
 
u
0

V
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z
K
M
 D
1






1
u
1
  (36) 
 
 
and the matrix operation could be rewritten as 
 
  
1 2   0
 1 2  0
0  1 2  0
0 O O O 0
0  1 2 
0  1

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where 
1
max 1
M
V z
K D


 
  
 
. 
As we can see from the above derivation, the problem has been converted to 
iteratively solving 1 ( )n nA B u = u  and the matrix equation gives them implicitly by the 
solution of simultaneous equations. The important thing to notice is that the matrix is 
tridiagonal, that is, except for three central diagonals all the elements of the matrix are 
zero. The solution to such a set of simultaneous equations may be economically obtained. 
In fact, this implicit method turns out to be cheaper in cost in comparison with a lot 
explicit method, since the increased accuracy allows the use of a much larger numerical 
choice of ∆t. 
Since the Crank-Nicolson method involves taking the derivative half way between 
the beginning and the end of the time space, it is hence an average between a fully 
implicit and fully explicit model of PDE’s. This is where the second-order convergence 
comes from, because essentially the first-order error term drops out from the averaging 
Suppose solution at tn, i.e.u(x, n∆t) is available, the following is a flow of chart for the 
solving procedure applying the Splitting Method. 
 
Step 1: Solve   , ,R t t



u
u x
t
 in  , 1 2t n t n t       inside the domain Ω using 
Crank Nicolson scheme. The solution we get from this step is  1 2, nt *u x ; 
Step 2: Use  1 2, nt *u x  as initial condition for 
2
D
 

  2
u u
t x
 and solve it in 
 , 1t n t n t       inside Ω using Runge-Kutta 2. The solution we get from this step is 
 1 2, nt **u x ; 
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Step 3: Solve   , ,R t t



u
u x
t
 again with initial condition  1 2, nt **u x  in 
 1 2 ,t n t n t       in Ω using Crank Nicolson scheme. The solution is  1, nt u x ; 
Step 4: Go back to Step 1 and work on the  ( 1) , 3 2t n t n t       . 
Although Operator-Splitting method has a second order of accuracy, it also has its 
drawbacks when it comes to a problem with discontinuous initial condition or the reaction 
term is not continuous in the space we are solving. The noise around discontinuity gets 
larger with time and eventually grows out of bound. To minimize the noise, we have to 
start with a really small delta t or big delta x. Small time step results in a fairly big matrix 
and time-consuming matrix operation. Big space step leads to rough lattice and less 
information about distribution of nucleotide and nucleoside concentrations in the space. 
However, the diffusion model doesn’t favor a rough lattice. If we consider a 20 μm 
height for ASL and the enzyme layer is only a couple of microns, the size of grid couldn’t 
exceed 1 micron. This results in a heavy and slow computation. Here we didn’t use the   
Due to the problem with the linearization of the boundary condition for adenosine and 
inosine and intensity of computation, we only studied dynamics of ATP, ADP and AMP 
using this method.  
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Appendix II: 
 
Model Equations 
Part I: Fluxes across membranes in each of the 3 compartments 
1. Apical ↔ intracellular (passive fluxes) 


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
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
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2. Intracellular ↔ basolateral region (passive, Na-K pump and Na-K-2Cl cotrasnport) 
































RT
FVZ
RT
FVZ
KK
RT
FVZP
J
bmK
bmK
cb
bmKbK
cbKPass
,
,
,,
,,
exp1
exp][][
 
































RT
FVZ
RT
FVZ
ClCl
RT
FVZP
J
bmCl
bmCl
cb
bmClbCl
cbClPass
,
,
,,
,,
exp1
exp][][
 
 25.1105
][
][
][
][
,
2
,
3
,
max,,
3
























 bm
Kpumpb
b
Napumpc
c
pumpcbpump V
KK
K
KNa
Na
JJ
cellbasopumpcellbasoNapump JJ   ,,, 3       cellbasopumpbasocellKpump JJ   ,,, 2  
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3. Apical ↔ intracellular region (passive fluxes) 
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Part II: Equations for ions and volumes in different compartments 
We assume that membranes are at equilibrium all the time. So membrane 
potentials (Vm,a, Vm,b and Vm,p) are calculated in the beginning of each iteration by 
solving the nonlinear equation system using Newton Raphson method. 




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0
0
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II
II
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Apical Region: 
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Intracellular Region: 
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Basolateral Region: 
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Appendix III: 
 
PROTOCOL OF MAKING BATHING SOLUTIONS 
 
Krebs Bicarbonate Ringers (KBR) * 
 Stock Solution (1L) Final Working Solution (1L) 
Compound Molarity M.W. g/L Volume of stock Molarity (mM) 
K2HPO4 48mM 174.18 8.36 50 ml 2.4 
KH2PO4 8.0mM 136.09 1.08 50 ml 0.4 
NaCl 2.3M 58.44 134.42 50 ml 115 
NaHCO3 500mM 84.01 42 50 ml 25 
CaCl22H2O 24mM 147.0 3.6 50 ml 1.2 
MgCl26H2O 24mM 203.30 4.88 50 ml 1.2 
 
 
1. Combine K2HPO4, KH2PO4, NaCl, and NaHCO3 
2. Add distilled H2O (700 ml) 
3. Gas for 30 minutes with 5% CO2 – 95% O2 
4. Add CaCl22H2O 
5. Add MgCl26H2O 
6. 0.92g D-glucose 
7. Filter 
 
 
Final Concentration (mM) 
Na 140 
K 5.2 
Ca 1.2 
HCO3
- 25 
Cl 120 
Mg 1.2 
Glucose 5.2 
* Keep solution well gassed and refrigerated to avoid precipitation. Warm before use. 
 
Chloride free KBR* 
 Stock Solution (1L) Final Working Solution (1L) 
Compound Molarity M.W. g/L Volume of stock Molarity (mM) 
K2HPO4 48mM 174.18 8.36 50 ml 2.4 
KH2PO4 8.0mM 136.09 1.08 50 ml 0.4 
Gluconic Acid (Na Salt) 575 mM 218.13 125.42 200 ml 115 
NaHCO3 500mM 84.01 42 50 ml 25 
Gluconic Acid (Ca Salt) 24.5mM 215.2 5.34 50 ml 1.2 
MgSO47H2O 21.6mM 246.5 5.34 50 ml 1.08 
 
 
1. Combine K2HPO4, KH2PO4, Na Gluconate, and 
NaHCO3 
2. Add distilled H2O (600 ml) 
3. Gas for 30 minutes with 5% CO2 – 95% O2 
4. Add Ca Gluconate 
5. Add MgSO47H2O 
6. 0.92g D-glucose 
7. Filter 
 
 
Final Concentration (mM) 
Na 140 
K 5.2 
Ca 1.2 
HCO3
- 25 
Gluconate 117.5 
Mg 1.08 
Glucose 5.2 
 
* Keep solution well gassed and refrigerated to avoid precipitation. Warm before use. 
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Chloride free KBR with 5mM Ba
2+ 
* 
 Stock Solution (1L) Final Working Solution (1L) 
Compound Molarity M.W. g/L Volume of stock Molarity (mM) 
K2HPO4 48mM 174.18 8.36 50 ml 2.4 
KH2PO4 8.0mM 136.09 1.08 50 ml 0.4 
Gluconic Acid (Na Salt) 575mM 218.13 125.42 200 ml 115 
NaHCO3 500mM 84.01 42 50 ml 25 
Gluconic Acid (Ca Salt) 24.5mM 215.2 5.34 50 ml 1.2 
Gluconic Acid (Mg Salt)** 21.6mM 207.3 8.95 50 ml 1.08 
BaCl2 5mM 244.27 1.22 No stock 5 
 
 
1. Combine K2HPO4, KH2PO4, Na Gluconate, and 
NaHCO3 
2. Add dH2O (600 ml) 
3. Gas for 30 minutes with 5% CO2 – 95% O2 
4. Add Ca Gluconate 
5. Add Mg Gluconate 
6. Add 0.92g D-glucose 
7. Put the solution in measuring cylinder and add 
distilled H2O to 1L 
8. Add 1.22g BaCl2 while keeping the solution well 
stirred 
9. Filter 
 
 
 
Final Concentration (mM) 
Na 140 
K 5.2 
Ca 1.2 
HCO3
- 25 
Cl 10 
Mg 1.08 
Ba 5 
Gluconate 119.7 
Glucose 5.2 
* Keep solution well gassed and refrigerated to avoid precipitation. Warm before use. 
** Mg Gluconate : Since Ba
2+
 reacts with SO4
2-
 and precipitates, SO4
2- 
needs to be 
replaced by Gl
-
.  Every MgGl molecule has half of Mg
2+
 and 1 Gl
-
.  
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